Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2020
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-35637
ASTA FUNDING, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 22-3388607 |
(State or other jurisdiction of incorporation or organization) | | (IRS Employer Identification No.) |
| |
210 Sylvan Ave., Englewood Cliffs, New Jersey | | 07632 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number: (201) 567-5648
Former name, former address and former fiscal year, if changed since last report: N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
Emerging growth company | | ☐ | | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act: |
| | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| | |
Common stock, par value $0.01 per share | ASFI | Nasdaq Global Select Market |
As of August 13, 2020, the registrant had 6,567,765 common shares outstanding.
ASTA FUNDING, INC. AND SUBSIDIARIES
INDEX TO FORM 10-Q
PARTI. FINANCIAL INFORMATION
Item 1. FinancialStatements
ASTA FUNDING, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
| | June 30, 2020 (Unaudited) | | | September 30, 2019 | |
ASSETS | | | | | | | | |
Cash and cash equivalents | | $ | 4,165,000 | | | $ | 4,308,000 | |
Available for sale debt securities (at fair value) | | | 44,001,000 | | | | 56,123,000 | |
Investments in equity securities (at fair value) | | | 26,580,000 | | | | 8,136,000 | |
Consumer receivables acquired for liquidation (at cost) | | | 997,000 | | | | 1,668,000 | |
Investment in personal injury claims, net | | | 3,642,000 | | | | 5,190,000 | |
Due from third party collection agencies and attorneys | | | 377,000 | | | | 596,000 | |
Accounts receivable, net | | | 182,000 | | | | 266,000 | |
Prepaid and income taxes receivable, net | | | 68,000 | | | | 264,000 | |
Furniture and equipment, net of accumulated depreciation of $2.0 million at June 30, 2020 and $1.9 million at September 30, 2019 | | | 48,000 | | | | 120,000 | |
Right of use assets | | | 362,000 | | | –– | |
Equity method investment | | | 307,000 | | | | 280,000 | |
Settlement receivable | | | 465,000 | | | | 1,558,000 | |
Deferred income taxes | | | 9,388,000 | | | | 9,631,000 | |
Goodwill | | | 1,410,000 | | | | 1,410,000 | |
Other assets | | | 1,438,000 | | | | 1,135,000 | |
Total assets | | $ | 93,430,000 | | | $ | 90,685,000 | |
LIABILITIES | | | | | | | | |
Accounts payable and accrued expenses | | $ | 1,219,000 | | | $ | 994,000 | |
Note payable | | | 1,118,000 | | | –– | |
Right of use liabilities | | | 370,000 | | | –– | |
Income taxes payable | | | 414,000 | | | | 787,000 | |
Total liabilities | | | 3,121,000 | | | | 1,781,000 | |
Commitments and contingencies | | | | | | | | |
| | | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | |
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding — none | | | — | | | | — | |
Preferred stock, Series A Junior Participating, $.01 par value; authorized 30,000 shares; issued and outstanding — none | | | — | | | | — | |
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,459,708 at June 30, 2020 and September 30, 2019; and outstanding 6,567,765 at June 30, 2020 and at September 30, 2019 | | | 135,000 | | | | 135,000 | |
Additional paid-in capital | | | 68,558,000 | | | | 68,558,000 | |
Retained earnings | | | 89,326,000 | | | | 87,907,000 | |
Accumulated other comprehensive income, net of taxes | | | 262,000 | | | | 276,000 | |
Treasury stock (at cost) 6,891,943 shares at June 30, 2020 and September 30, 2019 | | | (67,972,000 | ) | | | (67,972,000 | ) |
Total stockholders’ equity | | | 90,309,000 | | | | 88,904,000 | |
Total liabilities and stockholders’ equity | | $ | 93,430,000 | | | $ | 90,685,000 | |
See accompanying notes to condensed consolidated financial statements
ASTA FUNDING, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Unaudited)
| | Three Months | | | Three Months | | | Nine Months | | | Nine Months | |
| | Ended | | | Ended | | | Ended | | | Ended | |
| | June 30, 2020 | | | June 30, 2019 | | | June 30, 2020 | | | June 30, 2019 | |
Revenues: | | | | | | | | | | | | | | | | |
Finance income, net | | $ | 2,235,000 | | | $ | 3,684,000 | | | $ | 8,175,000 | | | $ | 10,659,000 | |
Personal injury claims income | | | 242,000 | | | | 439,000 | | | | 783,000 | | | | 1,608,000 | |
Disability fee income | | | 932,000 | | | | 1,175,000 | | | | 2,640,000 | | | | 3,732,000 | |
| | | | | | | | | | | | | | | | |
Total revenues | | | 3,409,000 | | | | 5,298,000 | | | | 11,598,000 | | | | 15,999,000 | |
| | | | | | | | | | | | | | | | |
Other Income: | | | | | | | | | | | | | | | | |
Interest and dividend income | | | 263,000 | | | | 821,000 | | | | 912,000 | | | | 1,274,000 | |
Gain on settlements | | –– | | | | 273,000 | | | | 30,000 | | | | 596,000 | |
Other income, net | | | 253,000 | | | | 34,000 | | | | 92,000 | | | | 121,000 | |
Total other income | | | 516,000 | | | | 1,128,000 | | | | 1,034,000 | | | | 1,991,000 | |
| | | | | | | | | | | | | | | | |
| | | 3,925,000 | | | | 6,426,000 | | | | 12,632,000 | | | | 17,990,000 | |
| | | | | | | | | | | | | | | | |
Expenses: | | | | | | | | | | | | | | | | |
General and administrative | | | 3,281,000 | | | | 2,980,000 | | | | 10,379,000 | | | | 10,301,000 | |
Interest | | | 1,000 | | | | — | | | | 1,000 | | | | — | |
Impairment | | –– | | | | 100,000 | | | | 23,000 | | | | 100,000 | |
Loss from equity method investment | | | 2,000 | | | | 5,000 | | | | 59,000 | | | | 91,000 | |
| | | 3,284,000 | | | | 3,085,000 | | | | 10,462,000 | | | | 10,492,000 | |
| | | | | | | | | | | | | | | | |
Income before income tax | | | 641,000 | | | | 3,341,000 | | | | 2,170,000 | | | | 7,498,000 | |
Income tax expense | | | 195,000 | | | | 1,037,000 | | | | 751,000 | | | | 2,146,000 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 446,000 | | | $ | 2,304,000 | | | $ | 1,419,000 | | | $ | 5,352,000 | |
| | | | | | | | | | | | | | | | |
Net income pershare: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.07 | | | $ | 0.35 | | | $ | 0.22 | | | $ | 0.80 | |
Diluted | | $ | 0.07 | | | $ | 0.35 | | | $ | 0.21 | | | $ | 0.80 | |
| | | | | | | | | | | | | | | | |
Weighted average number of common shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 6,567,765 | | | | 6,666,012 | | | | 6,567,765 | | | | 6,678,947 | |
Diluted | | | 6,748,499 | | | | 6,666,231 | | | | 6,686,081 | | | | 6,679,260 | |
See accompanying notes to condensed consolidated financial statements
ASTA FUNDING, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
June 30, 2020 and 2019
(Unaudited)
| | Three Months Ended June 30, 2020 | | | Three Months Ended June 30, 2019 | | | Nine Months Ended June 30, 2020 | | | Nine Months Ended June 30, 2019 | |
Comprehensive income is as follows: | | | | | | | | | | | | | | | | |
Net income | | $ | 446,000 | | | $ | 2,304,000 | | | $ | 1,419,000 | | | $ | 5,352,000 | |
| | | | | | | | | | | | | | | | |
Net unrealized debt securities gain (loss), net of tax (expense)/benefit of $51,000 and $46,000 during the three months ended June 30, 2020 and 2019, respectively, and $94,000 and ($40,000) during the nine months ended June 30, 2020 and 2019, respectively. | | | (133,000 | ) | | | (121,000 | ) | | | (240,000 | ) | | | 102,000 | |
Reclassification adjustment for securities sold, net of tax expense of $0 and $0 during the three months ended June 30, 2020 and 2019, respectively, and ($50,000) and $0 during the nine months ended June 30, 2020 and 2019, respectively. | | –– | | | –– | | | | 127,000 | | | –– | |
Foreign currency translation, net of tax (expense) / benefit of ($8,000) and ($6,000) during the three months ended June 30, 2020 and 2019, respectively, and ($38,000) and ($14,000) during the nine months ended June 30, 2020 and 2019, respectively. | | | (23,000 | ) | | | 16,000 | | | | 99,000 | | | | 52,000 | |
| | | | | | | | | | | | | | | | |
Other comprehensive (loss) income | | | (156,000 | ) | | | (105,000 | ) | | | (14,000 | ) | | | 154,000 | |
| | | | | | | | | | | | | | | | |
Total comprehensive income | | $ | 290,000 | | | $ | 2,199,000 | | | $ | 1,405,000 | | | $ | 5,506,000 | |
See accompanying notes to condensed consolidated financial statements
ASTA FUNDING, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)
| | Common Stock | | | Additional | | | | | | | Accumulated Other | | | | | | | Total | |
| | Issued Shares | | | Amount | | | Paid-in Capital | | | Retained Earnings | | | Comprehensive Income | | | Treasury Stock | | | Stockholders’ Equity | |
Balance, September 30, 2019 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 87,907,000 | | | $ | 276,000 | | | $ | (67,972,000 | ) | | $ | 88,904,000 | |
Net income | | | — | | | | — | | | | — | | | | 1,045,000 | | | | — | | | | — | | | | 1,045,000 | |
Unrealized loss on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | (128,000 | ) | | | — | | | | (128,000 | ) |
Amount reclassified from other comprehensive income | | | — | | | | — | | | | — | | | | — | | | | 122,000 | | | –– | | | | 122,000 | |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | (44,000 | ) | | | — | | | | (44,000 | ) |
Balance, December 31, 2019 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 88,952,000 | | | $ | 226,000 | | | $ | (67,972,000 | ) | | $ | 89,899,000 | |
Net loss | | | — | | | | — | | | | — | | | | (72,000 | ) | | | — | | | | — | | | | (72,000 | ) |
Unrealized gain on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | 21,000 | | | | — | | | | 21,000 | |
Amount reclassified from other comprehensive income | | | — | | | | — | | | | — | | | | — | | | | 5,000 | | | –– | | | | 5,000 | |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | 166,000 | | | | — | | | | 166,000 | |
Balance, March 31, 2020 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 88,880,000 | | | $ | 418,000 | | | $ | (67,972,000 | ) | | $ | 90,019,000 | |
Net income | | | — | | | | — | | | | — | | | | 446,000 | | | | — | | | | — | | | | 446,000 | |
Unrealized loss on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | (133,000 | ) | | | — | | | | (133,000 | ) |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | (23,000 | ) | | | — | | | | (23,000 | ) |
Balance, June 30, 2020 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 89,326,000 | | | $ | 262,000 | | | $ | (67,972,000 | ) | | $ | 90,309,000 | |
| | Common Stock | | | Additional | | | | | | | Accumulated Other | | | | | | | Total | |
| | Issued Shares | | | Amount | | | Paid-in Capital | | | Retained Earnings | | | Comprehensive Income | | | Treasury Stock | | | Stockholders’ Equity | |
Balance, September 30, 2018 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,551,000 | | | $ | 80,834,000 | | | $ | 35,000 | | | $ | (67,128,000 | ) | | $ | 82,427,000 | |
Cumulative effect of adjustment for adoption of ASC 606, net of tax of $80,000 | | | — | | | | — | | | | — | | | | 173,000 | | | | — | | | | — | | | | 173,000 | |
Cumulative effect of adjustment for adoption of ASU No. 2016-01, net of tax of $5,000 | | | — | | | | — | | | | — | | | | (10,000 | ) | | | 10,000 | | | | — | | | | — | |
Adjusted opening equity | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,551,000 | | | $ | 80,997,000 | | | $ | 45,000 | | | $ | (67,128,000 | ) | | $ | 82,600,000 | |
Stock based compensation expense | | | — | | | | — | | | | 7,000 | | | | — | | | | — | | | | — | | | | 7,000 | |
Net income | | | — | | | | — | | | | — | | | | 1,275,000 | | | | — | | | | — | | | | 1,275,000 | |
Unrealized gain on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | 135,000 | | | | — | | | | 135,000 | |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | 80,000 | | | | — | | | | 80,000 | |
Balance, December 31, 2018 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 82,272,000 | | | $ | 260,000 | | | $ | (67,128,000 | ) | | $ | 84,097,000 | |
Net income | | | — | | | | — | | | | — | | | | 1,773,000 | | | | — | | | | — | | | | 1,773,000 | |
Unrealized gain on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | 88,000 | | | | — | | | | 88,000 | |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | (44,000 | ) | | | — | | | | (44,000 | ) |
Balance, March 31, 2019 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 84,045,000 | | | $ | 304,000 | | | $ | (67,128,000 | ) | | $ | 85,914,000 | |
Net income | | | — | | | | — | | | | — | | | | 2,304,000 | | | | — | | | | — | | | | 2,304,000 | |
Unrealized loss on debt securities, net | | | — | | | | — | | | | — | | | | — | | | | (121,000 | ) | | | — | | | | (121,000 | ) |
Foreign currency translation, net | | | — | | | | — | | | | — | | | | — | | | | 16,000 | | | | — | | | | 16,000 | |
Treasury Stock purchased (79,500 shares) | | | — | | | | — | | | | — | | | | — | | | | — | | | | (560,000 | ) | | | (560,000 | ) |
Balance, June 30, 2019 | | | 13,459,708 | | | $ | 135,000 | | | $ | 68,558,000 | | | $ | 86,349,000 | | | $ | 199,000 | | | $ | (67,688,000 | ) | | $ | 87,553,000 | |
See accompanying notes to condensed consolidated financial statements
ASTA FUNDING, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| | Nine Months Ended | |
| | June 30, 2020 | | | June 30, 2019 | |
Cash flows from operating activities: | | | | | | | | |
Net income | | $ | 1,419,000 | | | $ | 5,352,000 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |
Depreciation and amortization | | | 72,000 | | | | 72,000 | |
Deferred income taxes | | | 287,000 | | | | 540,000 | |
Impairment of consumer receivables acquired for liquidation | | | 23,000 | | | | 100,000 | |
Stock based compensation | | –– | | | | 7,000 | |
Unrealized gain on equity securities | | | (67,000 | ) | | | (53,000 | ) |
Recoveries of bad debts – personal injury claims, net | | | (260,000 | ) | | | (90,000 | ) |
Loss from equity method investment | | | 59,000 | | | | 91,000 | |
Changes in: | | | | | | | | |
Receipt of income tax carry-back claim | | –– | | | | 3,231,000 | |
Prepaid and income taxes receivable | | | 196,000 | | | | (2,300,000 | ) |
Due from third party collection agencies and attorneys | | | 200,000 | | | | (69,000 | ) |
Accounts receivable | | | 84,000 | | | | (62,000 | ) |
Other assets | | | (304,000 | ) | | | (440,000 | ) |
Other liabilities | | | 325,000 | | | | (1,021,000 | ) |
Right of use assets | | | 274,000 | | | –– | |
Right of use liabilities | | | (266,000 | ) | | –– | |
Income taxes payable | | | (373,000 | ) | | –– | |
Net cash provided by operating activities | | | 1,669,000 | | | | 5,358,000 | |
Cash flows from investing activities: | | | | | | | | |
Principal collected on receivables acquired for liquidation | | | 599,000 | | | | 1,373,000 | |
Purchase of available for sale debt securities and investments in equity securities | | | (155,492,000 | ) | | | (92,194,000 | ) |
Proceeds from sale of available for sale debt securities | | | 149,080,000 | | | | 72,125,000 | |
Proceeds from note receivable | | | — | | | | 4,313,000 | |
Proceeds from settlement receivable | | | 1,093,000 | | | | 1,349,000 | |
Personal injury claims - advances | | | (390,000 | ) | | | (123,000 | ) |
Personal injury claims - receipts | | | 2,198,000 | | | | 5,049,000 | |
Increase in equity method investment | | | (86,000 | ) | | | (62,000 | ) |
Capital expenditures | | | — | | | | (117,000 | ) |
Net cash used in investing activities | | | (2,998,000 | ) | | | (8,287,000 | ) |
Cash flows from financing activities: | | | | | | | | |
Proceeds from note payable | | | 1,118,000 | | | –– | |
Purchase of treasury stock | | –– | | | | (560,000 | ) |
Net cash provided by (used in) financing activities | | | 1,118,000 | | | | (560,000 | ) |
Foreign currency effect on cash | | | 68,000 | | | | 103,000 | |
Net decrease in cash and cash equivalents | | | (143,000 | ) | | | (3,386,000 | ) |
Cash and cash equivalents at beginning of period | | | 4,308,000 | | | | 6,284,000 | |
Cash and cash equivalents at end of period | | $ | 4,165,000 | | | $ | 2,898,000 | |
Supplemental disclosure of cash flow information: | | | | | | | | |
Cash paid for: Interest | | $ | — | | | $ | — | |
Cash paid for: Income taxes | | $ | 700,000 | | | $ | 4,000,000 | |
Supplemental disclosure of non-cash operating activities: | | | | | | | | |
Initial recognition of right of use assets | | $ | 636,000 | | | $ | — | |
Initial recognition of right of use assets | | $ | 636,000 | | | $ | — | |
See accompanying notes to condensed consolidated financial statements
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation
Business
The Company, Asta Funding, Inc., a Delaware Corporation (“we” or “us”), together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”) (formerly known as Pegasus Funding, LLC (“Pegasus”)), Arthur Funding LLC (“Arthur Funding”) (formerly known as Practical Funding, LLC (“Practical Funding”)), and other subsidiaries, which are not all wholly owned, is engaged in several business segments in the financial services industry including funding of personal injury claims, through the Company's wholly owned subsidiaries Sylvave, Simia and Arthur Funding, social security disability advocacy through the Company's wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.
We operate principally in the United States in three reportable business segments: consumer receivables, social security disability advocacy and personal injury claims.
Consumer receivables
This segment is engaged in the business of purchasing, managing for its own account and servicing distressed charged off consumer receivables, including charged off receivables, and semi-performing receivables. Recently, our effort has been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. We acquire these consumer receivables at substantial discounts to their face values, based on the characteristics of the underlying accounts of each portfolio.
Personal injury claims
This segment is comprised of purchased interests in personal injury claims from claimants who are a party to a personal injury claim. The Company advances to each claimant funds on a non-recourse basis at an agreed upon fee, in anticipation of a future settlement. The Company capitalizes employee compensation and benefits expenses as direct costs related to the origination of personal injury advances. Claims purchased consist of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Practical Funding on March 16, 2018 to continue in the personal injury claims funding business. On April 8, 2019, Practical Funding changed its name to Arthur Funding, LLC. Arthur Funding began funding advances on personal injury claims in May 2019 (see Note 6).
Simia commenced operations in January 2017, and conducts its business solely in the United States. Simia obtained its business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business was also obtained from its website and through attorneys. The personal injury claims segment includes the consolidated results of operations of Sylvave, Simia and Arthur Funding. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal claim advances in the ordinary course.
Social security disability advocacy
This segment consists of advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental social security income benefits from the Social Security Administration and Department of Veterans Affairs. It relies upon Search Engine Optimization (“SEO”) to bring awareness to its intended market.
Basis of Presentation
The condensed consolidated balance sheet as of June 30, 2020, the condensed consolidated statements of operations for the three and nine months ended June 30, 2020 and 2019, the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended June 30, 2020 and 2019, the condensed consolidated statements of stockholders’ equity as of and for the three and nine months ended June 30, 2020 and 2019, and the condensed consolidated statements of cash flows for the nine months ended June 30, 2020 and 2019, are unaudited. The September 30, 2019 financial information included in this report was derived from our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019. In the opinion of management, all adjustments necessary to present fairly our financial position at June 30, 2020, the results of operations for the three and nine months ended June 30, 2020 and 2019, the condensed consolidated statement of comprehensive income (loss) for the three and nine months ended June 30, 2020 and 2019, the condensed consolidated statement of stockholders' equity for the three and nine months ended June 30, 2020 and 2019 and condensed consolidated cash flows for the nine months ended June 30, 2020 and 2019 have been made. The results of operations for the three and nine months ended June 30, 2020 and 2019 are not necessarily indicative of the operating results for any other interim period or the full fiscal year.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission and therefore do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in our 2019 Form 10-K filed with the Securities and Exchange Commission.
The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and industry practices.
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.
The condensed consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Going Private Transaction
On April 8, 2020 the Company announced that it has entered into a definitive merger agreement (the “Merger Agreement”) under which the Stern Group, comprised of Gary Stern, Chairman, President and Chief Executive Officer of the Company, Ricky Stern and certain related parties, will acquire all of the issued and outstanding shares of common stock of the Company through the merger of the Company with a wholly-owned subsidiary of Asta Finance Acquisition Inc. (“Parent”), with the Company surviving as a wholly-owned subsidiary of Parent (the “Merger”). Each share of outstanding common stock under the original Merger Agreement would have been purchased for $11.47 in cash.
The Merger was unanimously approved by the board of directors of Asta (the “Board”), acting on the unanimous recommendation of a special committee of independent and disinterested directors (the “Special Committee”) that was granted full authority to conduct a comprehensive strategic review and evaluate, and if warranted, negotiate an acquisition proposal. Subsequent to the approval of the Merger by the Board, on May 22, 2020, RBF Capital, LLC notified the Company’s Board of Directors, of its proposal to acquire all of the outstanding shares of the Company not currently held by RBF Capital, LLC for a price of $13.00 per
share in cash (the “RBF Capital Proposal”), representing a 13% premium to the Stern Investor Group’s proposed purchase price of $11.47 per share. The Special Committee evaluated the RBF Capital Proposal.
On June 25, 2020, the Company announced that it had entered into an amendment (the “Amendment”) to the Merger Agreement.
Pursuant to the amended Merger Agreement each share of outstanding common stock will be purchased for $13.10 in cash. The new purchase price represents an increase of $1.63 per share over the original purchase price and a premium of approximately 18% to the Company’s closing stock price on June 24, 2020, the last trading day prior to the execution of the Amendment.
The Merger Agreement and Amendment were approved by the board of directors of Asta (the “Board”) (without the participation of Gary Stern), acting on the unanimous recommendation of a special committee of independent and disinterested directors (the “Special Committee”) that was granted full authority to conduct a comprehensive strategic review and evaluate, and if warranted, negotiate an acquisition proposal. The Merger is subject to the satisfaction of customary closing conditions as well as the approval by the Company’s stockholders other than the Stern Group.
Simultaneously with the signing of the amended Merger Agreement, the Company also entered into a Settlement and Voting agreement with RBF Capital, LLC, a stockholder of the Company. Pursuant to the terms of the Settlement and Voting Agreement, RBF Capital, LLC has, among other things, agreed to vote the shares of Common Stock of the Company beneficially owned by RBF Capital, LLC, or that may become beneficially owned by it during the term of the Settlement and Voting Agreement, in favor of adopting the amended Merger Agreement, dated June 25, 2020, and any other matters necessary for consummation of the Merger (as defined in the Settlement and Voting Agreement) and the other transactions contemplated by the amended Merger Agreement.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
The Merger will be financed by a committed loan facility provided by Bank Leumi USA.
The Merger is expected to close in the Company’s fourth fiscal quarter of 2020 and is subject to the satisfaction of customary closing conditions as well as the approval by the Company’s stockholders other than the Stern Group. The Board recommends that Company’s stockholders vote to adopt and approve the Merger Agreement. Upon closing, the Company will become a privately held company and as such, the Company’s shares of common stock will no longer be listed or traded on the Nasdaq Global Select Market.
During the three and nine months ended June 30, 2020, the Company incurred fees and expenses in connection with the Merger of $668,000 and $1,453,000, respectively, included in general and administrative expenses on the accompanying consolidated statement of operations.
Risks and Uncertainties
Current economic uncertainty brought about as a result of the coronavirus 2019 (“COVID-19”) global pandemic may adversely impact the results of operations and liquidity of the Company overall and its business units to varying degrees over the near and longer term, particularly if the economic effects of the pandemic worsen or persist for an extended period of time.
A contributing factor to this expected near-term impact is that the COVID-19 pandemic has significantly impacted the ability of many consumers to pay their charged-off consumer receivable balances. In addition, the world-wide effect of this pandemic has been to drastically reduce employment both in the U.S. and abroad, and because employment is the greatest predictor of a consumer debtor to fulfill his or her obligations, diminished cash flows are probable in this segment. Our Personal Injury claims business relies on the adjudication of personal injury claims for which we purchase an interest in the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Most courthouses have temporarily closed and lawsuits are not being adjudicated. It is unclear as to when there will be a full reopening of the court system, and, as such, many cases will be held in abeyance as part of an already long-standing backlog.
Through June 30, 2020, our consumer receivables segment has experienced a downturn in cash collections attributable to consumer delays in making payments on their outstanding debts. Management attributes these delays to circumstances caused by COVID-19. Through June 30, 2020, our Personal Injury segment has not experienced noticeable delays in the adjudication of claims despite the fact that most courthouses have been temporarily closed. However, we have experienced customer payment delays due to COVID-19 impacts in our Peru operations.
While it is premature to quantify the impact of the evolving effects of COVID-19 and the effectiveness of measures taken by global governments to mitigate the pandemic and its economic impact, we expect COVID-19 will negatively impact the Company’s results of operations and its cash flows across both the consumer receivable and personal injury claim segments. The nature, extent and duration of the impact to the Company’s businesses will depend on implications to the general economic and financial markets, changes in economic variables, such as the availability of consumer credit, the ability of consumers to pay amounts owed to us; the effect on the rate of unemployment; the number and size of personal bankruptcy filings; the levels of consumer confidence and consumer debt; investor sentiment.; and any closures to our foreign offices. Additionally, government actions in response to the pandemic may hinder our collection activities or result in increased expenses.
Management is actively monitoring the impact of the global situation on our financial condition, liquidity, operations, and workforce. Given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 pandemic on its results of operations, financial condition, or liquidity for fiscal year 2020.
Concentration of Credit Risk – Cash and cash equivalents
The Company considers all highly liquid investments with a maturity date of three months or less at the date of purchase to be cash equivalents.
Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with two banks at June 30, 2020 that each exceeded the balance insured by the FDIC by approximately $0.6 million. Additionally, three foreign banks with an aggregate $1.7 million in cash balances are not FDIC insured. The Company does not believe it is exposed to any significant credit risk due to concentration of cash.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
Investments in Equity Securities
All equity investments in nonconsolidated entities are measured at fair value with changes recognized in earnings, except for those accounted for using the equity method of accounting. Changes in the fair value of equity securities are included in other income, net on the condensed consolidated statement of operations.
Available-for-Sale Debt Securities
Debt investments that the Company intends to hold for an indefinite period of time, but not necessarily to maturity, are classified as available-for-sale debt securities and are carried at fair value. Unrealized gains and losses on available-for-sale debt securities are determined using the specific-identification method. Unrealized gains/losses are recorded in other comprehensive income (loss).
Declines in the fair value of individual available-for-sale debt securities below their respective costs that are other than temporary will result in write-downs of the individual securities to their fair value. Factors affecting the determination of whether an other-than-temporary impairment has occurred include: a downgrading of the security by a rating agency, a significant deterioration in the financial condition of the issuer, or that management would not have the ability to hold a security for a period of time sufficient to allow for any anticipated recovery in fair value.
Personal Injury Claim Advances and Impairments
The Company accounts for its investments in personal injury claims at an agreed upon fee in anticipation of a future settlement. Purchased personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon fee, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.
Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collections of the fee income. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection of fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection of its initially funded cases as well as its fee income.
Income Recognition - Consumer Receivables
The Company accounts for certain of its investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 310, Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.
Under the guidance of ASC 310, the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. At such time, all cash collections are recognized as revenue when received.
Impairments - Consumer Receivables
The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC 310 permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value.
If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. The Company believes it has significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. The Company invests in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, it has the added benefit of soliciting its third party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and the Company’s ability to recover their cost basis.
Income Recognition - Social Security Disability Advocacy
In accordance with FASB ASC 606, Revenue from Contracts with Customers, the Company recognizes disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received or when the Company receives a notice of award from the Social Security Administration (“SSA”) or the Department of Veterans Affairs that stipulates the amount of fee approved by the SSA to be paid to the Company. The Company establishes a reserve for the differentials in amounts awarded by the SSA compared to the actual amounts received by the Company. Fees paid to the Company are withheld by the SSA against the claimant's disability claim award, and are remitted directly to the Company from the SSA.
Commissions and fees
Commissions and fees are the contractual commissions earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs and asset searches. The Company utilizes third party collection agencies and attorney networks.
Income taxes
Deferred federal and state taxes arise from (i) recognition of finance income collected for tax purposes, but not yet recognized for financial reporting; (ii) provision for impairments/credit losses, all resulting in timing differences between financial accounting and tax reporting; (iii) amortization of intangibles resulting in timing differences between financial accounting and tax reporting; (iv) stock based compensation; and (v) partnership investments.
Fair Value Hierarchy
FASB ASC 825, Financial Instruments, (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
The Company records its available-for-sale debt securities and investments in equity securities at estimated fair value on a recurring basis. The accompanying condensed consolidated financial statements include estimated fair value information regarding its available-for-sale debt securities and investments in equity securities as of March 31, 2020, as required by FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement.
Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurementdate.
Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are not active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3 - Unobservable inputs that are supported by little or no market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.
ASC 825 requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.
Recent Accounting Pronouncements
Adopted During the Nine Months EndedJune 30, 2020
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. For a lease with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or not exercise an option to terminate the lease. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842 (“ASU 2018-01”). ASU 2018-01 was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU 2016-02. Additionally, in July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU 2016-02 as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after December 15, 2018 and interim periods within those years, and early adoption is permitted (see Note 8 – Right of Use Assets).
The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on October 1, 2019, which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases at October 1, 2019, based on the Company's estimated borrowing rate for a collateralized loan. The Company had no debt outstanding as of October 1, 2019.
In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017, and requires certain disclosures about stranded tax effects. ASU 2018-02 was effective for the Company's fiscal year beginning October 1, 2019, with early adoption permitted, and was applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did not have a material impact on the Company’s condensed consolidated financial statements.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1—Business and Basis of Presentation (Continued)
Recent Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2022. Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. The Company does not believe this update will have a material impact on its consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning in fiscal 2022. The Company is evaluating the impact of the adoption of ASU 2019-12 on its financial statements, but does not expect such adoption to have a material impact.
Note 2—Investments in Debt and Equity Securities
Investments in Equity Securities
Investments in equity securities at June 30, 2020 and September 30, 2019, consist of mutual funds valued at $26.6 million and $8.1 million, respectively.
Net gains and losses recognized on investments in equity securities for the three and nine months ended June 30, 2020 and 2019 are as follows:
| | Three | | | Three | | | Nine | | | Nine | |
| | Months | | | Months | | | Months | | | Months | |
| | Ended | | | Ended | | | Ended | | | Ended | |
| | June 30, | | | June 30, | | | June 30, | | | June 30, | |
| | 2020 | | | 2019 | | | 2020 | | | 2019 | |
| | | | | | | | | | | | | | | | |
Unrealized gains and (losses) recognized during the reporting period on equity securities still held at the reporting date | | $ | 228,000 | | | $ | 32,000 | | | $ | 67,000 | | | $ | 53,000 | |
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 2—Investments in Debt and Equity Securities(Continued)
Available for Sale Debt Securities
Available for sale debt securities at June 30, 2020 and September 30, 2019, consist of the following:
| | Amortized | | | Unrealized | | | Unrealized | | | | |
June 30, 2020 | | Cost | | | Gains | | | Losses | | | Fair Value | |
Available for sale debt securities | | $ | 43,981,000 | | | $ | 23,000 | | | $ | 3,000 | | | $ | 44,001,000 | |
| | Amortized | | | Unrealized | | | Unrealized | | | | | |
September 30, 2019 | | Cost | | | Gains | | | Losses | | | Fair Value | |
Available for sale debt securities | | $ | 55,946,000 | | | $ | 178,000 | | | $ | 1,000 | | | $ | 56,123,000 | |
Unrealized holding gains and losses on available for sale debt securities are included in other comprehensive income (loss) within stockholders’ equity. Realized gains (losses) on available for sale debt securities are included in other income (loss) and, when applicable, are reported as a reclassification adjustment in other comprehensive income (loss).
Note 3—Consumer Receivables Acquired for Liquidation
Accounts acquired for liquidation are stated at cost and consist primarily of defaulted consumer loans of individuals primarily, throughout the United States and South America.
The following tables summarize the changes in the consolidated balance sheet account of consumer receivables acquired for liquidation during the following periods:
| | For the Three Months Ended June 30, | |
| | 2020 | | | 2019 | |
Balance, beginning of period | | $ | 1,193,000 | | | $ | 2,626,000 | |
| | | | | | | | |
Net cash collections from collection of consumer receivables acquired for liquidation | | | (2,421,000 | ) | | | (4,112,000 | ) |
Net cash collections represented by account sales of consumer receivables acquired for liquidation | | | — | | | | — | |
Impairment | | | — | | | | (100,000 | ) |
Effect of foreign currency translation | | | (10,000 | ) | | | 86,000 | |
Finance income recognized | | | 2,235,000 | | | | 3,684,000 | |
Balance, end of period | | $ | 997,000 | | | $ | 2,184,000 | |
Finance income as a percentage of collections | | | 92.3 | % | | | 89.6 | % |
| | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | |
Balance, beginning of period | | $ | 1,668,000 | | | $ | 3,749,000 | |
| | | | | | | | |
Net cash collections from collection of consumer receivables acquired for liquidation | | | (8,771,000 | ) | | | (12,026,000 | ) |
Net cash collections represented by account sales of consumer receivables acquired for liquidation | | | — | | | | — | |
Impairment | | | (23,000 | ) | | | (100,000 | ) |
Effect of foreign currency translation | | | (52,000 | ) | | | (98,000 | ) |
Finance income recognized | | | 8,175,000 | | | | 10,659,000 | |
Balance, end of period | | $ | 997,000 | | | $ | 2,184,000 | |
Finance income as a percentage of collections | | | 93.2 | % | | | 88.6 | % |
During the three and nine months ended June 30, 2020 and 2019 the Company did not purchase any new portfolios.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 3—Consumer Receivables Acquired for Liquidation (Continued)
As of June 30, 2020, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $0.7 million and $0.1 million, respectively. The total amount of internationally held consumer receivables acquired for liquidation was $0.8 million, or 79.5% of the $1.0 million in total consumer receivables held at June 30, 2020. Of the total consumer receivables four individual portfolios comprise 26.5%, 20.5%, 14.4% and 8.0% of the overall asset balance at June 30, 2020.
As of September 30, 2019, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $1.1 million and $0.3 million, respectively. The total amount of foreign consumer receivables acquired for liquidation was $1.4 million, or 83.8% of the total consumer receivables held of $1.7 million at September 30, 2019. Of the total consumer receivables held domestically and internationally 4 individual portfolios comprise 23.9%, 16.2%, 14.1% and 11.0% of the overall asset balance at September 30, 2019.
As of June 30, 2020, and September 30, 2019, 0.8% and 1.5% of the Company's total assets were related to its international operations, respectively. For the three and nine months ended June 30, 2020 and 2019, 6.2% and 3.9%, respectively, and 6.0% and 4.6%, respectively, of the Company's total revenue were related to its international operation.
At June 30, 2020, approximately 30% of the Company’s portfolio face value was serviced by five collection organizations. At September 30, 2019, approximately 28% of the Company’s portfolio face value was serviced by five collection organizations. The Company has servicing agreements in place with these five collection organizations, as well as all of the Company’s other third-party collection agencies and attorneys that cover standard contingency fees and servicing of the accounts. While the 5 collection organizations represent only 30% and 28% as of June 30, 2020 and September 30, 2019, respectively, of the Company’s portfolio face value, it does represent approximately 87% and 86% of the Company’s portfolio face value at all third-party collection agencies and attorneys as of June 30, 2020 and September 30, 2019, respectively.
The following table summarizes collections received by the Company’s third-party collection agencies and attorneys, less commissions and direct costs, for the three and nine months ended June 30, 2019 and 2018, respectively.
| | For the Three Months Ended June 30, | | | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | | | 2020 | | | 2019 | |
Gross collections (1) | | $ | 4,565,000 | | | $ | 7,680,000 | | | $ | 16,818,000 | | | $ | 23,262,000 | |
Commissions and fees (2) | | | (2,144,000 | ) | | | (3,568,000 | ) | | | (8,047,000 | ) | | | (11,236,000 | ) |
Net collections | | $ | 2,421,000 | | | $ | 4,112,000 | | | $ | 8,771,000 | | | $ | 12,026,000 | |
(1) | Gross collections include collections from third party collection agencies and attorneys, collections from in-house efforts and collections represented by account sales. |
(2) | Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also received a 3% fee on gross collections received by the Company in connection with the related portfolio purchase. The fee is charged for asset location and skip tracing in connection with this portfolio purchase. |
Note 4—Equity Method Investments
Serlefin Peru is a joint venture in which the Company has a 49% ownership interest. The other 51% is owned by three individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the 51% shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting. Under the joint venture agreement, the Company is entitled to a management fee from Serlefin Peru in connection with certain payments made to Serlefin Peru. In light of the novel coronavirus (“COVID-19”) pandemic, the Company agreed to delay the reimbursement of management fees due in April through December 2020.
Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of 80% and 20%, respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately $0.2 million and $0.2 million, and $0.9 million and $0.7 million in performance fees for the three and nine months ended June 30, 2020 and 2019, respectively. During June 2020, Serlefin Peru recapitalized $89,000 of loans due to the Company into equity in accordance with statutory requirements in Peru. Accordingly, the Company has reclassed $89,000 from other assets into equity method investment in its consolidated balance sheet at June 30, 2020. Further reclassifications of loans, as well as additional capital investments may be required to fund the ongoing operations of Serlefin Peru in the future.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 4—Equity Method Investments(Continued)
The operating results for Serlefin Peru were negatively impacted by COVID-19 during the three and nine months ended June 30, 2020. The carrying value of the investment in Serlefin Peru was $307,000 and $280,000 as of June 30, 2020 and September 30, 2019, respectively. The cumulative net loss from our investment in Serlefin Peru from the date of the initial investment through June 30, 2020 was approximately $311,000, and was not significant to the Company's condensed consolidated statement of operations. The Company has determined that there is no impairment of this investment at June 30, 2020.
Note 5—Personal Injury Claims Funding
Simia and Sylvave
As of June 30, 2020, Simia had a personal injury claims portfolio of $0.6 million, and recognized revenue for the three and nine months then ended of $97,000 and $168,000, respectively. As of September 30, 2019, Simia had a personal injury claims portfolio of $1.3 million, and recognized revenue of $31,000 and $60,000 for the three and nine months ended June 30, 2019, respectively.
As of June 30, 2020, Sylvave had a personal injury claims portfolio of $2.4 million, and recognized revenue for the three and nine months then ended of $128,000 and $568,000, respectively. As of September 30, 2019, Sylvave had a personal injury claims portfolio of $3.7 million. For the three and nine months ended June 30, 2019, Sylvave recognized revenue of $406,000 and $1,546,000, respectively.
Simia and Sylvave remain in operation to continue to collect on their outstanding personal injury claim portfolios, but will not be funding any new advances to claimants.
Arthur Funding
Arthur Funding began funding advances on personal injury claims in May 2019. As of June 30, 2020, Arthur Funding had a personal injury claims portfolio of $0.6 million, and recognized revenue for the three and nine months then ended of $26,000 and $56,000, respectively. As of September 30, 2019, Arthur Funding had a personal injury claims portfolio of $0.2 million, and recognized revenue for the three and nine months ended June 30, 2019 of $2,000.
The following tables summarize the changes in the balance sheet account of personal injury claim portfolios held by Simia, Sylvave and Arthur Funding, net of reserves, for the following periods:
| | For the Three Months ended June 30, | |
| | 2020 | | | 2019 | |
Balance, beginning of period | | $ | 3,709,000 | | | $ | 6,630,000 | |
Personal claim advances | | | 274,000 | | | | 123,000 | |
(Write offs) recoveries | | | 201,000 | | | | 248,000 | |
Personal injury claims income | | | 251,000 | | | | 439,000 | |
Personal injury claims receipts | | | (793,000 | ) | | | (1,531,000 | ) |
Balance, end of period | | $ | 3,642,000 | | | $ | 5,909,000 | |
| | For the Nine Months ended June 30, | |
| | 2020 | | | 2019 | |
Balance, beginning of period | | $ | 5,190,000 | | | $ | 10,745,000 | |
Personal claim advances | | | 390,000 | | | | 123,000 | |
(Write offs) recoveries | | | 260,000 | | | | 90,000 | |
Personal injury claims income | | | 792,000 | | | | 1,608,000 | |
Personal injury claims receipts | | | (2,990,000 | ) | | | (6,657,000 | ) |
Balance, end of period | | $ | 3,642,000 | | | $ | 5,909,000 | |
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 5—Personal Injury Claims Funding (Continued)
The Company recognized personal injury claims income of $0.3 million and $0.4 million for the three months ended June 30, 2020 and 2019, respectively, and $0.8 million and $1.6 million for the nine months ended June 30, 2020 and 2019, respectively. The personal injury claims income for the three and nine months ended June 30, 2020 excludes broker fees of $9,000 for both periods. The Company has recorded a reserve on principle fundings in personal injury claims of $1.0 million as of June 30, 2020 and $1.2 million as of September 30, 2019. During the three and nine months ended June 30, 2020, the Company realized personal injury bad debt recoveries of $201,000 and $260,000, respectively, as compared with $248,000 and $90,000 in the comparable periods of fiscal 2019, respectively.
Note 6—Non-Recourse Debt
Non-Recourse Debt –Bank of Montreal (“BMO”)
As of June 30, 2020, and September 30, 2019, the Company recorded a liability to BMO of approximately $75,000 and $22,000, respectively, which has been recorded in accounts payable and accrued expenses on the Company’s consolidated balance sheet. The funds were subsequently remitted to BMO on July 10, 2020 and October 10, 2019, respectively. The liability to BMO is recorded when actual collections are received.
Note 7 —Right of Use Assets and Liabilities
Effective October 1, 2019, the Company adopted ASU 2016-02, and all subsequent ASUs that modified Topic 842. For the Company, Topic 842 affected the accounting treatment for operating lease agreements in which the Company is the lessee by recognizing lease assets and liabilities on the balance sheet. The Company leases the premises for two New Jersey office facilities under operating lease agreements expiring in various years through 2023. The Company is responsible to pay all insurance, utilities, maintenance and repairs on the office spaces. All of the Company’s leases are classified as operating leases.
On October 1, 2019, the Company recorded lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments along with right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases on October 1, 2019. As of June 30, 2020, the Company’s operating lease right-of-use assets and operating lease liabilities were approximately $362,000 and $370,000, respectively.
The Company leases office space in Englewood Cliffs, New Jersey and subleases office space in Fort Lee, New Jersey under agreements classified as operating leases.
The lease agreement in Englewood Cliffs, New Jersey expires on August 31, 2020 and does not include any renewal option. The lease agreement provides for an initial monthly base amount plus annual escalations through the term of the lease.
The sublease agreement in Fort Lee, New Jersey expires on March 31, 2023 and does not include any renewal option. The lease agreement provides for an initial monthly base amount plus certain additional amounts pursuant to the leasing arrangement between the landlord and sublessor.
In adopting the new accounting guidance, the Company used the following practical expedients for transitional relief as provided for in ASU 2018-01:
●An entity need not reassess whether any expired or existing contracts are or contain leases.
●An entity need not reassess the lease classification for any expired or existing leases.
●An entity need not reassess initial direct costs for any existing leases.
●An entity may elect to apply hindsight to leases that existed during the period from the beginning of the earliest period presented in the financial statements until the effective date.
The Company also elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) or insignificant equipment leases on the condensed consolidated balance sheet as provided for in the accounting guidance.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 7 —Right of Use Assets and Liabilities (Continued)
The following provides additional information about the Company’s operating leases:
As of June 30, 2020: | | | | |
| | | | |
Weighted average remaining lease term (in years) | | | 2.40 | |
Weighted average discount rate | | | 3.5 | % |
As of June 30, 2020, the future minimum payments for the fiscal years are as follows:
2020 | | $ | 68,000 | |
2021 | | | 122,000 | |
2022 | | | 131,000 | |
2023 | | | 66,000 | |
Thereafter | | | – | |
| | | | |
Total lease payments | | | 387,000 | |
Less interest | | | (17,000 | ) |
Operating lease liability | | $ | 370,000 | |
The Company leases its facilities in (i) Englewood Cliffs, New Jersey, and (ii) Fort Lee, New Jersey. Rent expense for the three and nine months ended June 30, 2020 and 2019 was $0.1 million and $0.1 million and $0.3 million and $0.2 million, respectively.
On July 8, 2020, the Company entered into an agreement with its landlord to amend its lease for its corporate offices by terminating its tenancy for approximately 1,888 square feet of space as per the lease agreement dated October 7, 2015. Accordingly, rent due for this space is waived by the landlord and the Company waived any and all tenancy rights for this space. The Company’s remaining monthly rent for its corporate office is $14,000 or 82% of the current monthly rent. This change shall be effective as of August 1, 2020 and all other terms and conditions of the lease remain unchanged and in full effect.
Note 8 — Note Payable
On April 10, 2020, the Company applied for a $1.1 million Paycheck Protection Program (“PPP”) loan under the CARES Act. On May 11, 2020, the Company signed a PPP loan note with an interest rate of 1% and a May 11, 2022 maturity date, though PPP loans may be forgiven if certain conditions are met. The PPP loan was funded on May 20, 2020. During the quarter ended June 30, 2020, the Company used the proceeds of the PPP loan for payroll, lease payments and utility payments. The Company has not applied for PPP loan forgiveness.
Note 9 — Settlements
In August 2014, the Company filed a lawsuit in Delaware state court against a third-party servicer arising from the third-party servicer’s failure to pay the Company certain amounts that are due the Company under a servicing agreement. The third-party servicer filed a counterclaim in the Delaware action alleging that the Company owes certain amounts to the third-party servicer for court costs pursuant to an alleged arrangement between the companies. On or about July 12, 2018, the parties agreed to settle the action pursuant to a settlement agreement and release, which provides for, among other things, the payment by the third-party servicer of $4.4 million to the Company pursuant to an agreed upon schedule with a lump sum payment to be made at the third anniversary of the agreement.
These fee-based settlements are required to total $2.4 million and $4.4 million by the second and third anniversaries, respectively. To the extent that these fee-based settlement fees are less than these amounts, the servicer is required to make lump sum true-up payments.
The Company determined the fair value of this settlement using (i) historical collection history to estimate the fee based settlement fees that are expected to be received each month from the servicer; (ii) the contractual true-up dates, discussed above, in order to estimate the anticipated true-up payments that will be received from the servicer on the second and third anniversaries; and (iii) an imputed interest rate of 8.5%.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 9 — Settlements (Continued)
As of June 30, 2020, and September 30, 2019, the Company has a settlement receivable due from this third-party servicer of $0.5 million and $1.6 million, respectively. During the nine months ended June 30, 2020, the Company received $1.1 million in payments from this third-party servicer. For the three and nine months ended June 30, 2020 and 2019, the Company recorded interest income of $29,000 and $53,000 and $101,000 and $180,000, respectively, which is included in other income on the Company's consolidated statements of operations.
On January 22, 2018, DLCA, LLC ("DLCA"), a Delaware limited liability company and a wholly owned subsidiary of the Company, filed a complaint against Balance Point Divorce Funding, LLC. ("Balance Point") and Stacey Napp ("Napp") in the United States District Court of New Jersey, asserting various claims including breach of contract, conversion, unjust enrichment and fraud associated with a loan made to Balance Point and Napp in May 2012.
On May 22, 2019, Napp and DLCA entered into a Settlement Agreement that settled the action as well as all other claims for monies and/or other obligations owed as and between the parties.
Napp agreed to pay the sum of $1.4 million (the "Settlement Amount"), the payment terms of which are between May 21, 2019 and January 12, 2022.
The Company has previously reviewed the financial condition of both Balance Point and Napp, and has concluded that neither entity currently has assets sufficient to honor the obligations set forth in the Settlement Agreement. Therefore, due to the uncertainty of collecting the Settlement Amount from either Balance Point or Napp, the Company will realize the gain on this settlement, as the Company receives the cash proceeds. Napp missed the $25,000 payment due in December 2019 and made a $30,000 payment in February 2020. Napp missed the $25,000 payment due on May 31, 2020 and indicated to make up that payment by July 31, 2020, along with the regularly scheduled $25,000 payment that was due on July 31, 2020 under the Settlement Agreement. Napp missed the double payment of $50,000 due on July 31, 2020 and promised to make the double payment of $50,000 by September 30, 2020. The Company has recognized a gain on settlement of $0 and $30,000 for the three and nine months ended June 30, 2020 in its condensed consolidated statements of operations. The Company had recognized a gain on settlement of $25,000 for the three and nine months ended June 30, 2019 in its consolidated statements of operations.
On June 30, 2017, GAR Disability Advocates, filed a complaint against a former employee, Pamela Hofer ("Hofer"), and others in the United States Court for the District of New Jersey (the "Action"), asserting claims of conversion and tortious interference with existing business relationships. On May 22, 2018, the Action was transferred to the Eastern District of Kentucky.
On May 7, 2019, GAR agreed to dismiss and settle the Action for a payment from Hofer in the amount of $47,500, payable to GAR no later than May 8, 2019.
On May 8, 2019, GAR received the payment from Hofer, and delivered to Hofer an executed Stipulation of Dismissal of the Action. The Company recognized a gain on settlement of $47,500 for the three and nine months ended June 30, 2019 in its consolidated statements of operations.
On May 15, 2019, the Company received $0.2 million from the bankruptcy trustee in New Jersey, associated with the bankruptcy filing of Axiant, LLC, and a previous third-party servicer. The Company recorded a gain on settlement of $0.2 million for the three and nine months ended June 30, 2019 in its consolidated statements of operations.
Note 10 — Interest, Dividend and Other Income
The following tables summarize other income for the three and nine months ended June 30, 2020 and 2019:
| | For the Three Months Ended June 30, | |
| | 2020 | | | 2019 | |
Interest and dividend income | | $ | 263,000 | | | $ | 821,000 | |
Gain on settlements | | –– | | | | 273,000 | |
Unrealized gain on equity securities | | | 228,000 | | | | 33,000 | |
Other | | | 25,000 | | | | 1,000 | |
| | $ | 516,000 | | | $ | 1,128,000 | |
| | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | |
Interest and dividend income | | $ | 912,000 | | | $ | 1,274,000 | |
Gain on settlements | | | 30,000 | | | | 596,000 | |
Realized gain | | –– | | | | 25,000 | |
Unrealized gain on equity securities | | | 67,000 | | | | 53,000 | |
Other | | | 25,000 | | | | 43,000 | |
| | $ | 1,034,000 | | | $ | 1,991,000 | |
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 11—Commitments and Contingencies
Legal Matters
On November 7, 2019, a shareholder of the Company filed a verified shareholder derivative complaint in the Court of Chancery of the State of Delaware against certain current and former officers and directors of the Company, and named the Company as a nominal defendant, alleging that certain actions taken by management constituted a violation of fiduciary duty to the Company. The Company believes the lawsuit is without merit and intends to vigorously defend the matter. On or about January 8, 2020, a motion to dismiss the complaint was filed on behalf of all individual defendants and the Company as nominal defendant. In light of the execution of the merger agreement, the parties to the lawsuit entered into a joint stipulation and submitted a proposed order to stay proceedings in the lawsuit until the earlier of: (i) an announcement by the Company of the completion or cancellation of the merger, or (ii) June 30, 2020. On April 14, 2020, the court granted the parties’ stipulation and proposed order. On July 8, 2020, the court granted the parties' stipulation and proposed order to extend the stay until the earlier of: (i) an announcement by the Company of the completion or cancellation of the merger, or (ii) September 30, 2020.
In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of third-party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting their account. We do not believe that these ordinary course matters are material to our business and financial condition. The Company is not involved in any other material litigation in which we are a defendant.
Commitments
On June 9, 2020, a newly formed subsidiary of the Company entered into an agreement with a third party pursuant to which it will provide funding in connection with certain consumer lease transactions. Under the agreement, when a consumer is approved for financing at a participating merchant, the Company purchases the merchandise and then leases it to the consumer pursuant to a consumer lease agreement. The Company agreed to fund a maximum of $300,000 in total transactions, over a three-month period beginning with the date of the third party agreement. The Company did not make any funding payments during the month of June 2020.
Note 12—Income Taxes
At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and may change in subsequent interim periods. The Company’s effective tax rate from operations for the three and nine months ended June 30, 2020 was 30.4% and 34.6%, respectively, compared to 31.0% and 28.6%, respectively, for the same periods in the prior year.
The Company’s effective rate for the three months ended June 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to income from foreign operations, and state income taxes. The Company’s effective tax rate from operations for the nine months ended June 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to income from foreign operations resulting in income tax expense of $144,000, state income taxes and other differences discrete to the quarter.
The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The Company does not have any uncertain tax positions.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 12—Income Taxes (Continued)
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") was signed into law. The CARES Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense, class life changes to qualified improvements (in general, from 39 years to 15 years), and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years.
The income tax provisions of the CARES Act had limited applicability to the Company as of June 30, 2020, and therefore, the enactment of the CARES Act did not have a material impact on the Company’s condensed consolidated financial statements as of, and for the three and nine months ended, June 30, 2020. We will continue to evaluate the impact of tax legislation and will update our disclosures as additional information and interpretive guidance becomes available.
Note 13—Net Income (Loss) per Share
Basic per share data is determined by dividing net income (loss) by the weighted average shares outstanding during the period. Diluted per share data is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. The assumed proceeds from the exercise of dilutive options are calculated using the treasury stock method based on the average market price for the period.
The following table presents the computation of basic and diluted per share data for the three and nine months ended June 30, 2020 and 2019:
| | For the Three Months Ended June 30, 2020 | | | For the Three Months Ended June 30, 2019 | | | For the Nine Months Ended June 30, 2020 | | | For the Nine Months Ended June 30, 2019 | |
Net Income | | $ | 446,000 | | | $ | 2,304,000 | | | $ | 1,419,000 | | | $ | 5,352,000 | |
| | | | | | | | | | | | | | | | |
Basic earnings per share | | $ | 0.07 | | | $ | 0.35 | | | $ | 0.22 | | | $ | 0.80 | |
| | | | | | | | | | | | | | | | |
Diluted earnings per share | | $ | 0.07 | | | $ | 0.35 | | | $ | 0.21 | | | $ | 0.80 | |
| | | | | | | | | | | | | | | | |
Weighted average number of common shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 6,567,765 | | | | 6,666,012 | | | | 6,567,765 | | | | 6,678,947 | |
Dilutive effect of stock options | | | 180,734 | | | | 219 | | | | 118,316 | | | | 313 | |
Diluted | | | 6,748,499 | | | | 6,666,231 | | | | 6,686,081 | | | | 6,679,260 | |
At June 30, 2020 there were no stock options outstanding that were anti-dilutive. At June 30, 2019 there were 725,567 stock options outstanding that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive.
Note 14—Stock Option Plans
2012 Stock Option and Performance Award Plan
On February 7, 2012, the Company adopted the 2012 Stock Option and Performance Award Plan (the “2012 Plan”), which was approved by the stockholders of the Company on March 21, 2012. The 2012 Plan replaced the Equity Compensation Plan (as defined below).
The 2012 Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.
The Company authorized 2,000,000 shares of Common Stock for issuance under the 2012 Plan. Under the 2012 Plan, the Company has granted options to purchase an aggregate of 540,800 shares, awarded 245,625 shares of restricted stock, and has cancelled 118,668 options, leaving 1,332,243 shares available as of June 30, 2020. At June 30, 2020, 49 of the Company’s employees were able to participate in the 2012 Plan.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 14—Stock Option Plans (Continued)
Equity Compensation Plan
On December 1, 2005, the Company adopted the Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on March 1, 2006. The Equity Compensation Plan was adopted to supplement the Company’s 2002 Stock Option Plan (as defined below).
In addition to permitting the grant of stock options as are permitted under the 2002 Stock Option Plan, the Equity Compensation Plan allowed the Company flexibility with respect to equity awards by also providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights.
The Company authorized 1,000,000 shares of Common Stock for issuance under the Equity Compensation Plan. As of March 21, 2012, no more awards could be issued under this plan.
2002 Stock Option Plan
On March 5, 2002, the Company adopted the 2002 Stock Option Plan (the “2002 Plan”), which was approved by the stockholders of the Company on May 1, 2002. The 2002 Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company.
The 2002 Plan authorized the granting of incentive stock options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or not employees) and consultants of the Company.
The Company authorized 1,000,000 shares of Common Stock under the 2002 Plan. As of March 5, 2012, no more awards could be issued under this plan.
Summary of the Plans
Compensation expense for stock options and restricted stock is recognized over the requisite vesting or service period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date.
The following table summarizes stock option transactions under the 2012 Plan, the Equity Compensation Plan and the 2002 Plan (collectively the “Plans”):
| | For the Three Months Ended June 30, | |
| | 2020 | | | 2019 | |
| | Number Of Shares | | | Weighted Average Exercise Price | | | Number of Shares | | | Weighted Average Exercise Price | |
Outstanding options at the beginning of period | | | 666,867 | | | $ | 8.19 | | | | 726,767 | | | $ | 8.17 | |
Options exercised | | | — | | | | — | | | | — | | | | — | |
Options forfeited/cancelled | | | (100 | ) | | | 7.93 | | | | (1,200 | ) | | | 2.95 | |
Outstanding options at the end of period | | | 666,767 | | | $ | 8.19 | | | | 725,567 | | | $ | 8.18 | |
Exercisable options at the end of period | | | 666,767 | | | $ | 8.19 | | | | 725,567 | | | $ | 8.18 | |
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 14—Stock Option Plans (Continued)
| | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | |
| | Number Of Shares | | | Weighted Average Exercise Price | | | Number of Shares | | | Weighted Average Exercise Price | |
Outstanding options at the beginning of period | | | 722,567 | | | $ | 8.18 | | | | 728,867 | | | $ | 8.17 | |
Options exercised | | | — | | | | — | | | | — | | | | — | |
Options forfeited/cancelled | | | (55,800 | ) | | | 8.08 | | | | (3,300 | ) | | | 6.27 | |
Outstanding options at the end of period | | | 666,767 | | | $ | 8.19 | | | | 725,567 | | | $ | 8.18 | |
Exercisable options at the end of period | | | 666,767 | | | $ | 8.19 | | | | 725,567 | | | $ | 8.18 | |
The following table summarizes information about the Plans outstanding options as of June 30, 2020:
| | | | | Options Outstanding | | | Options Exercisable | |
Range of Exercise Price | | | Number of Shares Outstanding | | | Weighted Remaining Contractual Life (in Years) | | | Weighted Average Exercise Price | | | Number of Shares Exercisable | | | Weighted Average Exercise Price | |
$5.7501 | - | $8.6250 | | | | 557,267 | | | | 2.2 | | | | 7.96 | | | | 557,267 | | | | 7.96 | |
$8.6251 | - | $11.5000 | | | | 109,500 | | | | 2.6 | | | | 9.37 | | | | 109,500 | | | | 9.37 | |
| | | | | | 666,767 | | | | 2.2 | | | $ | 8.19 | | | | 666,767 | | | $ | 8.19 | |
The Company did not recognize any compensation expense related to the stock option grants during the three and nine months ended June 30, 2020. The Company recognized $0 and $7,000 of compensation expense related to the stock optionsvested during the three and nine months ended June 30, 2019, respectively. As of June 30, 2020, there was no unrecognized compensation cost related to stock option awards.
The intrinsic value of the outstanding and exercisable options as of June 30, 2020 was approximately $3,162,000. The weighted average remaining contractual life of exercisable options is 2.2 years. There were no options exercised during the three and nine months ended June 30, 2020 and 2019. The fair value of the stock options that vested during the three and nine months ended March 31, 2020 was approximately $0 for both periods. The fair value of the stock options that vested during the three and nine months ended June 30, 2019 was approximately $0 and $126,000, respectively. There were no options granted during the three and nine months ended June 30, 2020 and 2019.
The Company did not grant any restricted stock awards during the three and nine months ended June 30, 2020 and 2019. As of June 30, 2020, and September 30, 2019, there was no unrecognized compensation cost related to restricted stock awards.
Note 15—Stockholders’ Equity
The Company has 5,000,000 authorized preferred shares with a par value of $0.01 per share. The Board of Directors are authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes.
There were no shares of preferred stock issued and outstanding as of June 30, 2020 and 2019.
Dividends are declared at the discretion of the Board and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board deems relevant. In addition, agreements with the Company’s lenders may, fromtime to time, restrict the ability to pay dividends. As of June 30, 2020, there were no such restrictions. No dividends were declared during the three and nine months ended June 30, 2020.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 16—Fair Value of Financial Measurements and Disclosures
Fair Value of Financial Instruments
The estimated fair value of the Company’s financial instruments is summarized as follows:
| | June 30, 2020 | | | September 30, 2019 | |
| | Carrying Amount | | | Fair Value | | | Carrying Amount | | | Fair Value | |
Financial assets | | | | | | | | | | | | | | | | |
Cash equivalents (Level 1) | | $ | 645,000 | | | $ | 645,000 | | | $ | 64,000 | | | $ | 64,000 | |
Investments in equity securities (Level 1) | | | 26,580,000 | | | | 26,580,000 | | | | 8,136,000 | | | | 8,136,000 | |
Available-for-sale debt securities (Level 2) | | | 44,001,000 | | | | 44,001,000 | | | | 56,123,000 | | | | 56,123,000 | |
Consumer receivables acquired for liquidation (Level 3) | | | 997,000 | | | | 23,554,000 | | | | 1,668,000 | | | | 25,783,000 | |
Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments:
Cash equivalents - The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value.
Investments in equity securities - The investments in equity consist of mutual funds that are valued based on quoted prices in active markets.
Available-for-sale debt securities - The available-for-sale debt securities consist of U.S. treasury bills that are valued based on quoted prices in active markets. The U.S. treasury bills have been classified as available for sale by the Company, as they are deemed to be short term investments, and can be liquidated as needed by the Company.
The Company’s investments in equity securities and available-for-sale debt securities are classified as Level 1 and Level 2 financial instruments, respectively, based on the classifications described above. The Company did not have any transfers into (out of) Level 1 investments during the fiscal year ended September 30, 2019. The Company had no Level 3 available-for-sale investments during the three and nine months ended June 30, 2020.
Consumer receivables acquired for liquidation - The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of monthly collections for consumer receivables over the estimated collection period, which is currently July of 2020 through March of 2029. These cash flows are then fair valued using a discount rate of 20%. See Note 4 for the rollforward of Level 3 activity.
Note 17—Related Party
The Company utilizes the services of a consultant in conjunction with its international operations. The consultant is the spouse of one of the owners of Serlefin Peru. For the three and nine months ended June 30, 2020 and 2019, the Company paid this consultant $12,500 and $37,500, and $16,000 and $64,000, respectively. The Company does not have a formal agreement in place for these services, and the Company had no amounts due to this consultant as of June 30, 2020 and September 30, 2019.
On August 15, 2019, the Company and Lou Piccolo, a non-independent member of the Company’s Board of Directors, entered into a new one-year, $30,000 contract, pursuant to which Mr. Piccolo will provide consulting services. The compensation is to be paid quarterly. The Company recorded an expense of $7,500 and $23,650 for the three and nine months ended June 30, 2020. On July 18, 2020, the Companyand Mr. Piccolo entered into a six-month, $15,000 contract, pursuant to which Mr. Piccolo will continue toprovide consulting services to the Company. The compensation is to be paid quarterly in the amount of $7,500 on August 15, 2020 and November 30, 2020. There were no amounts due to Mr. Piccolo at June 30, 2020 and September 30, 2019.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 18—Segment Reporting
The Company operates through strategic business units that are aggregated into three reportable segments: Consumer receivables, personal injury claims and social security disability advocacy. The three reportable segments consist of the following:
| • | Consumer receivables - This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumerreceivables, including judgment receivables, charged off receivables and semi-performing receivables. Judgment receivables are accounts where outside attorneys have secured judgments directly against the consumer. Primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of our distressed consumer receivables are MasterCard®, Visa® and other credit card accounts which were charged-off by the issuers or providers for non-payment. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. Recently, the Company's efforts have been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. The Company holds consumers receivable acquired for liquidation in both Colombia and Peru of approximately $0.8 million. The business conducts its activities primarily under the name Palisades Collection, LLC. |
| • | Personal injury claims – This segment is comprised of purchased interests in personal injury claims from claimants who are a party in personal injury litigation or claims. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Arthur Funding, on March 16, 2018 to continue in the personal injury claims funding business. Arthur Funding began funding advances on personal injury claims in May 2019. Arthur Funding, Simia and Sylvave conduct its businesses solely in the United States and obtains business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business is also obtained from its website and through attorneys. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal injury claim advances in the ordinary course. |
| • | Social Security benefit advocacy – GAR Disability and Five Star are advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental security income benefits from the Social Security and Veterans Administration. |
Certain non-allocated administrative costs, interest income and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, investments in equity securities and available-for-sale debt securities, a note receivable, property and equipment, goodwill, deferred taxes and other assets.
ASTA FUNDING, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 18—Segment Reporting (Continued)
The following table shows results by reporting segment for the three and nine months ended June 30, 2020 and 2019:
(Dollars in millions) | | Consumer Receivables | | | Social Security Disability Advocacy | | | Personal Injury Claims | | | Corporate (2) | | | Total | |
Three Months Ended June 30, | | | | | | | | | | | | | | | | | | | | |
2020: | | | | | | | | | | | | | | | | | | | | |
Revenues | | $ | 2.2 | | | $ | 0.9 | | | $ | 0.3 | | | $ | — | | | $ | 3.4 | |
Other income | | | — | | | | — | | | | — | | | | 0.5 | | | | 0.5 | |
Segment profit (loss) | | | 2.0 | | | | 0.1 | | | | 0.4 | | | | (1.9 | ) | | | 0.6 | |
2019: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 3.7 | | | | 1.2 | | | | 0.4 | | | | — | | | | 5.3 | |
Other income | | | 0.2 | | | | — | | | | — | | | | 0.9 | | | | 1.1 | |
Segment profit (loss) | | | 3.3 | | | | 0.4 | | | | 0.6 | | | | (1.0 | ) | | | 3.3 | |
Nine Months Ended June 30, | | | | | | | | | | | | | | | | | | | | |
2020: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 8.2 | | | | 2.6 | | | | 0.8 | | | | — | | | | 11.6 | |
Other income | | | 0.1 | | | | — | | | | — | | | | 0.9 | | | | 1.0 | |
Segment profit (loss) | | | 7.1 | | | | 0.3 | | | | 0.8 | | | | (6.0 | ) | | | 2.2 | |
Segment Assets (1) | | | 6.0 | | | | 1.0 | | | | 4.1 | | | | 82.3 | | | | 93.4 | |
2019: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 10.7 | | | | 3.7 | | | | 1.6 | | | | — | | | | 16.0 | |
Other income | | | 0.7 | | | | — | | | | — | | | | 1.3 | | | | 2.0 | |
Segment profit (loss) | | | 9.9 | | | | 1.2 | | | | 1.5 | | | | (5.1 | ) | | | 7.5 | |
Segment Assets (1) | | | 9.1 | | | | 0.6 | | | | 6.2 | | | | 74.5 | | | | 90.4 | |
The Company does not have any intersegment revenue transactions.
(1) | Includes other amounts in other line items on the consolidated balance sheet. |
(2) | Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment. |
Note 19–Subsequent Events
On August 13, 2020, the Company entered into a sale and assignment agreement with a third party (Assignor) and purchased the Assignor’s rights, title and interest in a certain litigation funding agreement in the amount of $675,000.
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Caution Regarding Forward Looking Statements
The “COVID-19” pandemic, and measures taken to mitigate the pandemic, could cause actual results to differ materially from those set forth in the forward-looking statements, particularly if the pandemic persists for an extended period of time both domestically and internationally. While it is difficult to predict the extent to which the evolving effects of COVID-19 and measures taken to mitigate the pandemic, they may impact us, they could have an adverse effect on our results of operations and cash flows, particularly as they affect general economic and financial markets, changes in economic variables, such as the availability of consumer credit, the ability of consumers to pay amounts owed to us, the housing market, energy costs, the number and size of personal bankruptcy filings, the rate of unemployment, the levels of consumer confidence and consumer debt, and investor sentiment. Additionally, government actions in response to the pandemic may hinder our collection activities or result in increased expenses.
This Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included or incorporated by reference in this report, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objective of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” or “believes” or the negative thereof or any variation there on or similar terminology or expressions.
We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation, the impact of the COVID-19 pandemic on general political and economic conditions, including as a result of efforts by governmental authorities to mitigate the COVID-19 pandemic, such as travel bans, shelter in place orders and third-party business closures and resource allocations, our ability to execute our business continuity as well as our operational and budget plans in light of the COVID-19 pandemic, our ability to consummate the proposed Merger, satisfaction of closing conditions to the consummation of the proposed Merger, the impact of the announcement or the closing of the Merger on the Company’s relationships with its employees, existing customers or potential future customers, the ability to realize anticipated benefits of the proposed Merger, the restatement of previously issued financial statements, the identified material weaknesses in our internal control over financial reporting and our ability remediate those material weaknesses, our ability to purchase defaulted consumer receivables at appropriate prices, changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables, our ability to employ and retain qualified employees, changes in the credit or capital markets, changes in interest rates, deterioration in economic conditions, negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and statements of assumption underlying any of the foregoing, as well as other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019.
All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise any forward-looking statements.
Overview
Asta Funding, Inc., a Delaware Corporation (the “Company,” “we” or “us”), together with our wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”) (formerly known as Pegasus Funding, LLC (“Pegasus”)), Arthur Funding LLC (“Arthur Funding”) (formerly known as Practical Funding, LLC (“Practical Funding”)), and other subsidiaries, which are not all wholly owned, are engaged in several business segments in the financial services industry including funding of personal injury claims, through our wholly owned subsidiaries Sylvave, Simia and Arthur Funding, social security disability advocacy through our wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for our own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.
For the period October 1, 2017 to January 12, 2018, Pegasus was 80% owned, but not controlled, and accounted for under the equity method. On January 12, 2018 (“Date of Acquisition”), we acquired the remaining 20% minority interest and a controlling financial interest, in Pegasus and changed its name to Sylvave and now own 100% of Sylvave. Commencing on the Date of Acquisition, we consolidated the financial results of this entity.
We operate principally in the United States in three reportable business segments: consumer receivables, social security disability advocacy and personal injury claims.
For a detailed description of our segments, please read Note 19 – Segment Reporting, in our notes to condensed consolidated financial statements.
Going Private Transaction
On April 8, 2020 the Company announced that it has entered into a definitive merger agreement (the “Merger Agreement”) under which the Stern Group, comprised of Gary Stern, Chairman, President and Chief Executive Officer of the Company, Ricky Stern and certain related parties, will acquire all of the issued and outstanding shares of common stock of the Company through the merger of the Company with a wholly-owned subsidiary of Asta Finance Acquisition Inc. (“Parent”), with the Company surviving as a wholly-owned subsidiary of Parent (the “Merger”). Each share of outstanding common stock under the original Merger Agreement would have been purchased for $11.47 in cash.
The Merger was unanimously approved by the board of directors of Asta (the “Board”), acting on the unanimous recommendation of a special committee of independent and disinterested directors (the “Special Committee”) that was granted full authority to conduct a comprehensive strategic review and evaluate, and if warranted, negotiate an acquisition proposal. Subsequent to the approval of the Merger by the Board, on May 22, 2020, RBF Capital, LLC notified the Company’s Board of Directors, of its proposal to acquire all of the outstanding shares of the Company not currently held by RBF Capital, LLC for a price of $13.00 per share in cash (the “RBF Capital Proposal”), representing a 13% premium to the Stern Investor Group’s proposed purchase price of $11.47 per share. The Special Committee evaluated the RBF Capital Proposal.
On June 25, 2020, the Company announced that it had entered into an amendment (the “Amendment”) to the Merger Agreement.
Pursuant to the amended Merger Agreement each share of outstanding common stock will be purchased for $13.10 in cash. The new purchase price represents an increase of $1.63 per share over the original purchase price and a premium of approximately 18% to the Company’s closing stock price on June 24, 2020, the last trading day prior to the execution of the Amendment.
The Merger Agreement and Amendment were approved by the board of directors of Asta (the “Board”) (without the participation of Gary Stern), acting on the unanimous recommendation of a special committee of independent and disinterested directors (the “Special Committee”) that was granted full authority to conduct a comprehensive strategic review and evaluate, and if warranted, negotiate an acquisition proposal. The Merger is subject to the satisfaction of customary closing conditions as well as the approval by the Company’s stockholders other than the Stern Group.
Simultaneously with the signing of the amended Merger Agreement, the Company also entered into a Settlement and Voting agreement with RBF Capital, LLC, a stockholder of the Company. Pursuant to the terms of the Settlement and Voting Agreement, RBF Capital, LLC has, among other things, agreed to vote the shares of Common Stock of the Company beneficially owned by RBF Capital, LLC, or that may become beneficially owned by it during the term of the Settlement and Voting Agreement, in favor of adopting the amended Merger Agreement, dated June 25, 2020, and any other matters necessary for consummation of the Merger (as defined in the Settlement and Voting Agreement) and the other transactions contemplated by the amended Merger Agreement.
The Merger will be financed by a committed loan facility provided by Bank Leumi USA.
The Merger is expected to close in the Company’s fourth fiscal quarter of 2020 and is subject to the satisfaction of customary closing conditions as well as the approval by the Company’s stockholders other than the Stern Group. The Board recommends that Company’s stockholders vote to adopt and approve the Merger Agreement. Upon closing, the Company will become a privately held company and as such, the Company’s shares of common stock will no longer be listed or traded on the Nasdaq Global Select Market.
During the three and nine months ended June 30, 2020, the Company incurred fees and expenses in connection with the Merger of $668,000 and $1,453,000, respectively, included in general and administrative expenses on the accompanying consolidated statement of operations.
Risks and Uncertainties
The novel coronavirus 2019 (“COVID-19”) outbreak emerged in late 2019 and was declared a global pandemic by the World Health Organization on March 11, 2020. Current economic uncertainty brought about as a result of COVID-19 global pandemic may adversely impact the results of operations and liquidity of the Company overall and its business units to varying degrees over the near and longer term, particularly if the economic effects of the pandemic worsen or persist for an extended period of time.
A contributing factor to this expected near-term impact is that the COVID-19 pandemic has significantly impacted the ability of many consumers to pay their charged-off consumer receivable balances. In addition, the world-wide effect of this pandemic has been to drastically reduce employment both in the U.S. and abroad, and because employment is the greatest predictor of a consumer debtor to fulfill his or her obligations, diminished cash flows are probable in this segment. Accordingly, while we cannot quantify the expected effects, we believe revenues and cash collections generated by our Consumer Receivables business are likely to be below our budgeted expectations for at least the remainder of 2020. For the three months ended June 30, 2020, we did experience a downturn in cash collections attributable to consumer delays in making payments on their outstanding debts. Management attributes these delays to circumstances caused by COVID-19 and expects additional delays in customer payments in future periods. We have also experienced customer payment delays due to COVID-19 impacts in our Peru operations.
Our Personal Injury claims business relies on the adjudication of personal injury claims for which we purchase an interest in the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Most courthouses have temporarily closed and lawsuits are not being adjudicated. It is unclear as to when there will be a full reopening of the court system, and, as such, many cases will be held in abeyance as part of an already long-standing backlog. Our Personal Injury segment has not experienced noticeable delays in the adjudication of claims despite the fact that most courthouses have been temporarily closed. While we cannot quantify the effects of this downward trend, we believe COVID-19 may negatively impact the results of future operations and cash flows related to this segment.
While it is premature to quantify the impact of the evolving effects of COVID-19 and the effectiveness of measures taken by global governments to mitigate the pandemic and its economic impact, we expect COVID-19 will negatively impact the Company’s results of operations and its cash flows. The nature, extent and duration of the impact to the Company’s businesses will depend on implications to the general economic and financial markets, changes in economic variables, such as the availability of consumer credit, the ability of consumers to pay amounts owed to us; the effect on the rate of unemployment; the number and size of personal bankruptcy filings; the levels of consumer confidence and consumer debt; investor sentiment; and any closures to our foreign offices. Additionally, government actions in response to the pandemic may hinder our collection activities or result in increased expenses.
Management is actively monitoring the impact of the global situation on our financial condition, liquidity, operations, and workforce. Given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 pandemic on its results of operations, financial condition, or liquidity for fiscal year 2020.
Financial Information About Operating Segments
The consumer receivables segment and the social security benefit advocacy segment each accounted for 10% or more of consolidated net revenue for the three and nine months ended June 30, 2020 and 2019. The personal injury claims segment accounted for its investment in Sylvave under the equity method of accounting through January 12, 2018, for subsequent periods we included the financial results of Sylvave in our consolidated statement of operations, while Simia is a consolidated entity. The following table summarizes total revenues by percentage from our three lines of business for the three and nine months ended June 30, 2020 and 2019:
| | For the Three Months Ended June 30, | | | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | | | 2020 | | | 2019 | |
Finance income (consumer receivables) | | | 65.6 | % | | | 69.5 | % | | | 70.5 | % | | | 66.6 | % |
Personal injury claims income | | | 7.1 | | | | 8.3 | | | | 6.7 | | | | 10.1 | |
Disability fee income | | | 27.3 | | | | 22.2 | | | | 22.8 | | | | 23.3 | |
Total revenues | | | 100.0 | % | | | 100.0 | % | | | 100.0 | % | | | 100.0 | % |
Information about the results of each of our reportable segments for the three and nine months ended June 30, 2020 and, 2019, reconciled to the consolidated results, are set forth below. Separate segment MD&A is not provided, as segment revenue corresponds to the revenue presented in our condensed consolidated statement of operations, and material expense items are not allocable to any specific segment.
(Dollars in millions) | | Consumer Receivables | | | Social Security Disability Advocacy | | | Personal Injury Claims | | | Corporate (2) | | | Total | |
Three Months Ended June 30, | | | | | | | | | | | | | | | | | | | | |
2020: | | | | | | | | | | | | | | | | | | | | |
Revenues | | $ | 2.2 | | | $ | 0.9 | | | $ | 0.3 | | | $ | — | | | $ | 3.4 | |
Other income | | | — | | | | — | | | | — | | | | 0.5 | | | | 0.5 | |
Segment profit (loss) | | | 2.0 | | | | 0.1 | | | | 0.4 | | | | (1.9 | ) | | | 0.6 | |
2019: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 3.7 | | | | 1.2 | | | | 0.4 | | | | — | | | | 5.3 | |
Other income | | | 0.2 | | | | — | | | | — | | | | 0.9 | | | | 1.1 | |
Segment profit (loss) | | | 3.3 | | | | 0.4 | | | | 0.6 | | | | (1.0 | ) | | | 3.3 | |
Nine Months Ended June 30, | | | | | | | | | | | | | | | | | | | | |
2020: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 8.2 | | | | 2.6 | | | | 0.8 | | | | — | | | | 11.6 | |
Other income | | | 0.1 | | | | — | | | | — | | | | 0.9 | | | | 1.0 | |
Segment profit (loss) | | | 7.1 | | | | 0.3 | | | | 0.8 | | | | (6.0 | ) | | | 2.2 | |
Segment Assets (1) | | | 6.0 | | | | 1.0 | | | | 4.1 | | | | 82.3 | | | | 93.4 | |
2019: | | | | | | | | | | | | | | | | | | | | |
Revenues | | | 10.7 | | | | 3.7 | | | | 1.6 | | | | — | | | | 16.0 | |
Other income | | | 0.7 | | | | — | | | | — | | | | 1.3 | | | | 2.0 | |
Segment profit (loss) | | | 9.9 | | | | 1.2 | | | | 1.5 | | | | (5.1 | ) | | | 7.5 | |
Segment Assets (1) | | | 9.1 | | | | 0.6 | | | | 6.2 | | | | 74.5 | | | | 90.4 | |
We do not have any intersegment revenue transactions.
(1) | Includes other amounts in other line items on the consolidated balance sheet. |
(2) | Corporate is not part of our three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment |
Consumer Receivables
The consumer receivable portfolios generally consist of one or more of the following types of consumer receivables:
| • | charged-off receivables — accounts that have been written-off by the originators and may have been previously serviced by collection agencies; and |
| • | semi-performing receivables — accounts where the debtor is making partial or irregular monthly payments, but the accounts may have been written-off by the originators. |
We acquire these consumer receivable portfolios at a significant discount to the amount actually owed by the borrowers. We acquire these portfolios after a qualitative and quantitative analysis of the underlying receivables and calculate the purchase price so that our estimated cash flow offers us an adequate return on our investment after servicing expenses. After purchasing a portfolio, we actively monitor its performance and review and adjust our collection and servicing strategies accordingly.
We purchase receivables from credit grantors and others through privately negotiated direct sales, brokered transactions and auctions in which sellers of receivables seek bids from several pre-qualified debt purchasers. We pursue new acquisitions of consumer receivable portfolios on an ongoing basis through:
| • | our relationships with industry participants, financial institutions, collection agencies, investors and our financing sources; |
| • | brokers who specialize in the sale of consumer receivable portfolios; and |
Personal Injury Claims
This Company’s personal injury claims business segment is comprised of purchased interests in personal injury claims from claimants who are a party in personal injury litigation or claims. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Arthur Funding, on March 16, 2018 to continue in the personal injury claims funding business. Arthur Funding began funding advances on personal injury claims in May 2019. Arthur Funding, Simia and Sylvave conduct its businesses solely in the United States and obtains business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business is also obtained from its website and through attorneys. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal injury claim advances in the ordinary course.
Disability Advocacy Business
GAR Disability Advocates and Five Star are disability advocacy groups, which for a fee obtain and represent individuals in their claims for social security disability, supplemental security income benefits from the Social Security Administration and veterans’ benefits with the Veteran's Administration.
Critical Accounting Policies
Income Recognition - Consumer Receivables
We account for certain of our investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method, we concluded the cost recovery method is the appropriate accounting method under the circumstances.
Under the guidance of ASC 310-30, we must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).
We use the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.
Impairments - Consumer Receivables
We account for our impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on us having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event we cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected. ASC 310 permits the change to the cost recovery method. We will recognize income only after we have recovered our carrying value.
If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. We believe we have significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. We invest in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom we have limited experience, it has the added benefit of soliciting its third-party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and our ability to recover our cost basis. For the three and nine months ended June 30, 2020, we recorded impairment of our international portfolios by $0 and $23,000, respectively.For the three and nine months ended June 30, 2019, we recorded impairment of our international portfolios by $100,000for both periods.
Personal Injury Claim Advances and Impairments
We account for our investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. Our interest purchased in personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.
We assess the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. We specifically reserve for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, we establish reserves based on the historical collection rates of our fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, we also monitor our historical collection rates on fee income and establish reserves on fee income consistent with the historically experienced collection rates. We regularly analyze and update the historical collection rates of our initially funded cases as well as our fee income.
Income Recognition - Social Security Disability Advocacy
In accordance with FASB ASC 606, Revenue from Contracts with Customers, we recognize disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received, or when we receive a notice of award from the Social Security Administration (“SSA”) that stipulates the amount of fee approved by the SSA to be paid to us. We establish a reserve for the differentials in amounts awarded by the SSA and Veterans Administration compared to the actual amounts received by us. Fees paid to us are withheld by the SSA and Veterans Administration against the claimant's disability claim award, and are remitted directly to us from the SSA and Veterans Administration.
In the following discussions, most percentages and dollar amounts have been rounded to aid in the presentation. As a result, all figures are approximations.
Results of Operations
Nine Months Ended June 30, 2020, Compared to the Nine Months Ended June 30, 2019
Finance income. For the nine months ended June 30, 2020, finance income decreased $2.5 million, or 23.3%, to $8.2 million from $10.7 million for the nine months ended June 30, 2019. During the nine months ended June 30, 2020 and 2019 the Company did not purchase any consumer portfolios. Net collections for the nine months ended June 30, 2020 decreased 27.1% to $8.8 million from $12.0 million for the same prior year period. During the first nine months of fiscal year 2020, gross collections decreased 27.7% or $6.5 million to $16.8 million from $23.3 million for the nine months ended June 30, 2019. Commissions and fees associated with gross collections from our third-party collection agencies and attorneys decreased $3.2 million, or 28.4%, to $8.0 million for the nine months ended June 30, 2020 from $11.2 million for the nine months ended June 30, 2019. Commissions and fees amounted to 47.8% of gross collections for the nine months ended June 30, 2020, compared to 48.3% in the same period of the prior year, due to a higher percentage of commissionable collections in the prior year period.
Management’s outlook for our Consumer Receivables business segment is that we expect that Finance income may continue to decline due to the continued aging of our existing credit card portfolios. Although we may purchase new portfolios in future periods, we may not be able to purchase consumer receivable portfolios domestically at favorable prices or on sufficient terms. The expected decline in our future Finance income may have a negative impact on our Consumer Receivables business segment and our consolidated pre-tax profits in the remainder of fiscal 2020 and future periods.
Personal Injury Claims income.Personal injury claims income decreased 51.3% or $0.8 million to $0.8 million for the nine months ended June 30, 2020 from $1.6 million for the nine months ended June 30, 2019 as a result of lower new advances in Arthur Funding partially offset by continued collections on historical personal injury claims.
Disability fee income. For the nine months ended June 30, 2020, disability fee income decreased $1.1 million, or 29.3%, to $2.6 million as compared to $3.7 million for the nine months ended June 30, 2019, due to decreases in average fees per case earned for the disability claimants’ cases closed with the Social Security and Veterans Administration during the current period.
Management’s outlook for our Social Security Disability Advocacy business segment is that revenue and segment profitability may be lower for the full year of fiscal 2020 as compared with the full year of fiscal 2019. This full year outlook for fiscal 2020 is attributable to the decline in our first and second quarter revenues and segment profits in the first three quarters of fiscal 2020 as compared with the first three quarters of fiscal 2019 and the fourth quarter of fiscal 2019.
Earnings (loss) from equity method investee.Loss from equity method investment decreased by $32,000 to a loss of $59,000 for the nine months ended June 30, 2020 from a loss of $91,000 during the nine months ended June 30, 2019.
Gain on Settlement. For the nine months ended June 30, 2020, the Company recognized $30,000 in gain on settlement. For the nine months ended June 30, 2019, the Company recognized $0.6 million in gain on settlement associated with prior overcharges billed to the Company by a third-party servicer in excess of contractually permitted amounts, a bankruptcy settlement from a previous third party service provider, a gain on settlement associated with Balance Point Divorce Funding and Stacey Napp and a gain on settlement associated with a complaint against a former employee.
Interest and dividend income. Interest and dividend income decreased $0.4 million, or 28.4% to $0.9 million for the nine months ended June 30, 2020 from $1.3 million for the nine months ended June 30, 2019, due primarily to lower interest rates on U.S. Treasury securities.
Other income (loss), net. The following table summarizes other income (loss) for the nine months ended June 30, 2020 and 2019:
| | For the Nine Months Ended June 30, | |
| | 2020 | | | 2019 | |
Realized gain | | $ | — | | | $ | 25,000 | |
Unrealized gain on equity securities | | | 67,000 | | | | 53,000 | |
Other | | | 25,000 | | | | 43,000 | |
| | $ | 92,000 | | | $ | 121,000 | |
General and administrative expenses. For the nine months ended June 30, 2020, general and administrative expenses increased $0.1 million to $10.4 million from $10.3 million for the nine months ended June 30, 2019, primarily due to an increase in outside services cost of $1.3 millionoffset by a decrease in professional fees of $0.5 million,payroll expenses of $0.4 million, bad debt expense of $0.2 million and collection expenses of $0.1 million. During the nine months ended June 30, 2020, the Company incurred fees and expenses in connection with the Merger of $1.4 million.
Interest expense. Interest expense for the nine months ended June 30, 2020, was $1,000 attributable to the Company’s recently added loan payable as compared to no interest expense for the nine months ended June 30, 2019.
Segment profit – Consumer Receivables. For the nine months ended June 30, 2020, segment profit decreased $2.8 million to $7.1 million from $9.9 million for the nine months ended June 30, 2019, primarily due to the decrease in revenue of $2.5 million, and decrease in other income of $0.6 million offset by a decrease in collection expense of $0.1 million and payroll expenses of $0.2 million.
Segment profit – Personal Injury Claims. For the nine months ended June 30, 2020, segment profit was $0.8 million as compared to segment profit of $1.5 million for the nine months ended June 30, 2019. The decrease is attributable to decrease in revenue of $0.8 million partially offset by various lower operating expenses of $0.1 million.
Segment profit – Social Security Benefit Advocacy. For the nine months ended June 30, 2020, segment profit was $0.3 million as compared to $1.2 million for the same period in the prior year. The decrease in profit of $0.9 million in the current period is primarily the result of decreased revenues of $1.1 million partially offset by a reduction in overhead expenses of $0.2 million.
Income tax (benefit) expense. Income tax expense, consisting of federal and state components, for nine months ended June 30, 2020, was $0.8 million, as compared to an income tax expense of $2.1 million for the nine months ended June 30, 2019.
Net income (loss). As a result of the above, the Company had net income for the nine months ended June 30, 2020 of $1.5 million compared to $5.4 million net income for the nine months ended June 30, 2019.
Three Months Ended June 30, 2020, Compared to the Three Months Ended June 30, 2019
Finance income. For the three months ended June 30, 2020, finance income decreased $1.5 million, or 39.3%, to $2.2 million from $3.7 million for the three months ended June 30, 2019. The decrease in finance income is due to a reduction in the collections on portfolios during the three months ended June 30, 2020 compared to the three months ended June 30, 2019 and the overall age of the portfolios. During the three months ended June 30, 2020 and 2019, the Company did not purchase any consumer portfolios. Net collections for the three months ended June 30, 2020 decreased 41.1% to $2.4 million from $4.1 million for the three months ended June 30, 2019. For the three months ended June 30, 2020 gross collections decreased 40.6%, or $3.1 million, to $4.6 million from $7.7 million for the three months ended June 30, 2019. For the three months ended June 30, 2020 commissions and fees associated with gross collections from our third-party collection agencies and attorneys decreased 39.9% or $1.5 million to $2.1 million from $3.6 million for the three months ended June 30, 2019. Commissions and fees amounted to 47.0% of gross collections for the three months ended June 30, 2020, compared to 46.5% for the three months ended June 30, 2019 resulting from higher percentage of commissionable collections in the current year period.
Personal Injury Claims income. Personal injury claims income decreased 44.9% or $0.2 million to $0.2 million for the three months ended June 30, 2020 from $0.4 million for the three months ended June 30, 2019 as a result of lower new advances in Arthur Funding partially offset by continued collections on historical personal injury claims.
Social security benefit advocacy fee income. For the three months ended June 30, 2020, disability fee income decreased $0.3 million, or 20.7%, to $0.9 million as compared to $1.2 million for the three months ended June 30, 2019, due to decreases in average fees per case earned for the disability claimants’ cases closed with the Social Security and Veterans Administration during the current period.
Earnings (loss) from equity method investee. Loss from equity method investment was $2,000 for the three months ended June 30, 2020 as compared to a loss of a loss of $5,000 for the three months ended June 30, 2019.
Gain on Settlement. For the three months ended June 30, 2020, the Company did not recognize any gain on settlement. For the three months ended June 30, 2019, the Company recognized $0.3 million in gain on settlement associated with a bankruptcy settlement from a previous third-party servicer, a gain on settlement with Balance Point Divorce Funding and Stacey Napp and a gain on settlement with a former employee.
Other income, net. The following table summarizes other income for the three months ended June 30, 2020 and 2019:
| | For the Three Months Ended June 30, | |
| | 2020 | | | 2019 | |
Unrealized gain on equity securities | | $ | 228,000 | | | $ | 33,000 | |
Other | | | 25,000 | | | | 1,000 | |
| | $ | 253,000 | | | $ | 34,000 | |
General and administrative expenses. For the three months ended June 30, 2020, general and administrative expenses increased $0.2 million, or 5.9%, to $3.2 million from $3.0 million for the three months ended June 30, 2019, primarily due to an increase in outside services cost of $0.4 million offset by a decrease in bad debt expense of $0.2 million. During the three months ended June 30, 2020, the Company incurred fees and expenses in connection with the Merger of $0.6 million.
Segment profit – Consumer Receivables. Segment profit decreased $1.3 million to $2.0 million for the three months ended June 30, 2020 from $3.3 million for the three months ended June 30, 2019. This decrease in profitability is a result of decreased revenue of $1.5 million partially offset by a decrease in impairment cost of $0.1 million, and decreases in various operating expenses of $0.1 million.
Segment profit – Personal Injury Claims. Segment profit decreased $0.2 million to $0.4 million for the three months ended June 30, 2020, from $0.6 million for the three months ended June 30, 2019. This decrease in profitability is primarily due to decreased revenue of $0.2 million.
Segment profit – Social Security Disability Advocates. The Segment profit was $0.1 million for the three months ended June 30, 2020 as compared $0.4 million for the three months ended June 30, 2019. The decrease in profitability of $0.3 million is primarily the result of decreased revenue of $0.3 million.
Income tax expense– Income tax expense, consisting of federal and state components, for three months ended June 30, 2020, was $0.2 million, as compared to $1.0 million for the three months ended June 30, 2019, primarily due to lower income in the current year period.
Net income (loss)– As a result of the above, we generated net income for the three months ended June 30, 2020 of $0.5 million, compared to $2.3 million for the three months ended June 30, 2019.
Liquidity and Capital Resources
We manage our liquidity and capital resources to fund our operating and investing activities. We rely on cash flows from operations as the main source for liquidity.
Our primary source of cash from operations is collections on the receivable portfolios we have acquired and the funds generated from the liquidation of our personal injury claim portfolios.
Our primary uses of cash include costs involved in the collection of consumer receivables, the liquidation of our personal injury portfolio, and the costs to run our disability advocacy business.
At June 30, 2020, the Company had $4.2 million in cash and cash equivalents, as well as $70.6 million in investments in debt and equity securities on hand and $1.1 in debt. In addition, the Company had $90.4 million in stockholders’ equity at June 30, 2020.
Current economic uncertainty brought about as a result of the coronavirus 2019 (“COVID-19”) global pandemic may adversely impact the results of operations and liquidity of the Company overall and its business units to varying degrees over the near term, particularly if the economic effects of the pandemic worsen or persist for an extended period of time. As a result of the evolving effects of the COVID-19 on our businesses, we are continuing to evaluate our liquidity position and cash flows to ensure we are judiciously utilizing our cash.
In recognition of expected reductions in future operating cash flows, on April 10, 2020, the Company applied for a $1.1 million Paycheck Protection Program (“PPP”) loan under the CARES Act. On May 11, 2020, the Company signed a PPP loan note with an interest rate of 1% and a May 11, 2022 maturity date, though PPP loans may be forgiven if certain conditions are met. The PPP loan was funded on May 20, 2020.
Receivables Financing Agreement
As of June 30, 2020, we recorded a liability to BMO of approximately $0.1 million. The funds were subsequently remitted to BMO on July 10, 2020. The liability to BMO is recorded when actual collections are received.
Cash Flow
At June 30, 2020, our cash decreased $0.1 million to $4.2 million from $4.3 million at September 30, 2019. Our cash balance remained consistent; due to the fact we invested all excess cash in U.S. Treasury bills, which are accounted for as available for sale debt securities on our condensed consolidated balance sheet.
Net cash provided by operating activities was $1.7 million during the nine months ended June 30, 2020, as compared to $5.4 million provided by operating activities for the nine months ended June 30, 2019, primarily resulting from the net income of $1.4 million in the current period compared to a net income of $5.4 million in the prior year period. Net cash used in investing activities was $3.0 million during the nine months ended June 30, 2020, as compared to $8.3 million used in investing activities during the nine months ended June 30, 2019. The change in cash provided by (used in) investing activities was primarily due to the net purchase of available for sale debt securities and investments in equity securities of ($6.4) million in the current period compared to ($20.1) million in the prior period, lower collection from receivables acquired for liquidation of ($0.8) million,lower receipts from personal injury claims of ($2.8) million in the current year and proceeds from notes receivable of $4.3 million in the prior year period. Cash provided by financing activities during the nine months ended June 30, 2020 was $1.1 million from the PPP loan. Cash used in financing activities during the nine months ended June 30, 2019 was $0.6 million. The cash used in financing activities during the prior year was due to the purchase of treasury stock of $0.6 million.
Our cash requirements have been and will continue to be significant to operate our various lines of business. Significant requirements include costs involved in the collections of consumer receivables, investment in consumer receivable portfolios and investment in personal injury claims. In addition, dividends could be declared and paid if and when approved by the Board. Acquisitions recently have been financed through cash flows from operating activities. We believe we will not be dependent on a credit facility in the short-term, as our cash balances will be sufficient to invest in personal injury claims, purchase portfolios and finance the disability advocacy business.
We do not expect to incur any material capital expenditures during the next twelve months.
We believe our available cash resources and expected cash flows from operations will be sufficient to fund operations for at least the next twelve months.
We are cognizant of the current market fundamentals in the debt purchase and company acquisition markets which, because of significant supply and tight capital availability, could result in increased buying opportunities.The outcome of any future transaction(s) is subject to market conditions. In addition, due to these opportunities, we may seek opportunities with banking organizations and others on a possible financing loan facility.
Off Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Additional Supplementary Information:
We do not anticipate collecting the majority of the purchased principal amounts of our various portfolios. Accordingly, the difference between the carrying value of the portfolios and the gross receivables is not indicative of future revenues from these accounts acquired for liquidation. Since we purchased these accounts at significant discounts, we anticipate collecting only a portion of the face amounts.
For additional information regarding our methods of accounting for our investment in finance receivables, the qualitative and quantitative factors we use to determine estimated cash flows, and our performance expectations of our portfolios, see “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” above.
Recent Accounting Pronouncements
Adopted During The Nine Months Ended June 30, 2020
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. For a lease with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or not exercise an option to terminate the lease. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842 (“ASU 2018-01”). ASU 2018-01 was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU 2016-02. Additionally, in July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU 2016-02 as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after December 15, 2018 and interim periods within those years, and early adoption is permitted (see Note 8 – Right of Use Assets).
The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on October 1, 2019, which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases at October 1, 2019, based on the Company's estimated borrowing rate for a collateralized loan. The Company had no debt outstanding as of October 1, 2019.
In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017, and requires certain disclosures about stranded tax effects. ASU 2018-02 was effective for the Company's fiscal year beginning October 1, 2019, with early adoption permitted, and was applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did not have a material impact on the Company’s condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2022. Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. The Company does not believe this update will have a material impact on its consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning in fiscal 2022. The Company is evaluating the impact of the adoption of ASU 2019-12 on its financial statements, but does not expect such adoption to have a material impact.
Item 4. | Controls and Procedures |
Disclosure Controls and Procedures
Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2020. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2020 due to the existence of the material weaknesses in internal control over financial reporting described below (which we view as an integral part of our disclosure controls and procedures).
We did not design and implement effective control over our control environment, risk assessment, control activities and monitoring activities with regard to our processes and procedures commensurate with our financial reporting requirements which we determined to be material weaknesses. Specifically, our control deficiencies are in the following areas:
Control Environment and Risk Assessment:
| ● | The Company did not design and implement a sufficient level of formal financial reporting and operating policies and procedures that define how transactions are initiated, processed, approved, recorded and appropriately reported and disclosed within the annual and interim consolidated financial statements. |
| ● | The Company did not maintain sufficient policies and procedures to ensure that financial statement disclosures are complete, accurate and comply with professional standards. |
| ● | The Company did not maintain a sufficient number of personnel with the necessary level of accounting knowledge, experience, and training in the application of U.S. GAAP commensurate with its financial reporting requirements and the complexity of the Company’s operations and transactions. In addition, the Company lacked appropriate segregation of duties over certain accounting processes, including the approval and authorization of certain transactions. |
Control Activities:
| ● | The Company did not maintain and document control activities designed and implemented to identify, review and report, on a timely basis, related party transactions, and account for unusual, non-recurring complex transactions and income taxes. |
| ● | The Company did not maintain and document internal controls with sufficient precision designed to provide reasonable assurance related to third party service providers and third-party advocates providing cash collection and advocacy services including the completeness and accuracy of related information. |
Monitoring Activities:
The Company did not maintain effective monitoring and review activities including communicating deficiencies in a timely manner to those parties responsible for taking corrective action.
Changes in Internal Controls over Financial Reporting.
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated our internal control over financial reporting to determine whether any changes occurring during the third quarter of fiscal year 2020 that have materially affected, or are reasonably likely to affect, our internal control over financial reporting.
The Company identified an additional material weakness during our third quarter of fiscal 2020. Specifically, the Company identified a control deficiency relating to proper segregation of duties over certain accounting processes, including the approval and authorization of certain transactions.
Management has concluded that there have been no other changes that occurred during such quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PARTII. OTHER INFORMATION
Item 1. | Legal Proceedings |
In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of third-party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting their account. We do not believe that these ordinary course matters are material to our business and financial condition. The Company is not involved in any other material litigation in which we are a defendant.
Originators, debt purchasers and third-party collection agencies and attorneys in the consumer credit industry are frequently subject to putative class action lawsuits and other litigation. Claims include failure to comply with applicable laws and regulations and improper or deceptive origination and servicing practices. Being a defendant in such class action lawsuits or other litigation could materially adversely affect our results of operations and financial condition.
Legal proceedings are subject to substantial uncertainties concerning the outcome of material factual and legal issues relating to the litigation. Accordingly, we cannot currently predict the manner and timing of the resolution of some of these matters and may be unable to estimate a range of possible losses or any minimum loss from such matters.
On November 7, 2019, a shareholder of the Company filed a verified shareholder derivative complaint in the Court of Chancery of the State of Delaware against certain current and former officers and directors of the Company, and named the Company as a nominal defendant, alleging that certain actions taken by management constituted a violation of fiduciary duty to the Company. The Company believes the lawsuit is without merit and intends to vigorously defend the matter. On or about January 8, 2020, a motion to dismiss the complaint was filed on behalf of all individual defendants and the Company as nominal defendant. In light of the execution of the merger agreement, the parties to the lawsuit entered into a joint stipulation and submitted a proposed order to stay proceedings in the lawsuit until the earlier of: (i) an announcement by the Company of the completion or cancellation of the merger, or (ii) June 30, 2020. On April 14, 2020, the court granted the parties’ stipulation and proposed order. On July 8, 2020, the court granted the parties' stipulation and proposed order to extend the stay until the earlier of: (i) an announcement by the Company of the completion or cancellation of the merger, or (ii) September 30, 2020.
For a discussion of our potential risks and uncertainties, see the information previously disclosed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K, for the year ended September 30, 2019 filed with the SEC on December 20, 2019. With the exception of the following, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K.
Our results of operations have been adversely affected and could in the future be materially adversely impacted by the COVID-19 pandemic
The global spread of the COVID-19 pandemic has created significant economic volatility, uncertainty and disruption. The extent to which the COVID-19 pandemic impacts our business, operations and financial results will depend on numerous evolving factors that we may not be able to accurately predict, including: the duration and scope of the pandemic; governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic; the impact of the pandemic on economic activity and actions taken in response; changes in economic variables, such as the availability of consumer credit; the ability of consumers to pay amounts owed to us; the effect on the housing market; the rate of unemployment; the number and size of personal bankruptcy filings; the effect on energy costs; the levels of consumer confidence and consumer debt; and investor sentiment. Additionally, government actions in response to the pandemic may hinder our collection activities or result in increased expenses.
Cyber-attacks and other malicious internet-based activity continue to increase generally, and cloud-based platform providers of software and services have been targeted. Due to the COVID-19 pandemic, many of our employees are temporarily working remotely, which may pose additional data security risks.
Management is actively monitoring the impact of the global situation on our financial condition, liquidity, operations, and workforce. Given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 pandemic on its results of operations, financial condition, or liquidity for fiscal year 2020. Any of these events could cause or contribute to the risks and uncertainties enumerated in the Annual Report and could materially adversely affect our business, financial condition, results of operations and/or stock price.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
None
Item 3. | Default Upon Senior Securities |
None
Item 4. | Mine Safety Disclosures |
Not applicable
None
| (a) Exhibits. |
| |
31.1* | Certification of Gary Stern, Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
31.2* | Certification of Steven Leidenfrost, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
32.1* | Certification of Gary Stern, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
32.2* | Certification of Steven Leidenfrost, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
101.INS | XBRL Instance. |
| |
101.SCH | XBRL Taxonomy Extension Schema. |
| |
101.CAL | XBRL Taxonomy Extension Calculation. |
| |
101.DEF | XBRL Taxonomy Extension Definition. |
| |
101.LAB | XBRL Taxonomy Extension Labels. |
| |
101.PRE | XBRL Taxonomy Extension Presentation. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ASTA FUNDING, INC. (Registrant) |
| | |
Date: August 14, 2020 | By: | /s/ Gary Stern |
| | Gary Stern, President, Chief Executive Officer |
| | (Principal Executive Officer) |
| | |
Date: August 14, 2020 | By: | /s/ Steven Leidenfrost |
| | Steven Leidenfrost, Chief Financial Officer |
| | (Principal Financial Officer and Principal Accounting Officer) |